Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription factor binding	SETD1A MAGEA11 MAGEA12 IRX5 PPRC1 ASCL5 DACT2 KLF14 CAMTA2 PAGR1 JUN HSF1 FOS PCLO TACC2 PPARG MED1 GRM1 ZFPM2 NCOA1 DOT1L TP53BP1	5.90e-05	753	229	22	GO:0008134
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	PPRC1 ASCL5 DAB2 KLF14 CAMTA2 PAGR1 HOXB2 JUN BRCA1 ATXN7 GLI2 MED22 MAMSTR CREB3L3 HSF1 FOXJ1 FOXM1 TFEC FOS ZNF407 PPARG MED1 PAF1 RFX2 ZFPM2 SBNO2 CASK USF3 EGR3 ZNF335 NCOA1 ELF3 TNKS DOT1L TP53BP1	4.12e-06	1390	228	35	GO:0045944
GeneOntologyBiologicalProcess	regulation of DNA metabolic process	WAPL RTEL1 BCL7B PAGR1 JUN TMEM161A BRCA1 ATXN7 GLI2 FGFR4 HSF1 FOXM1 WRAP53 USP37 SH2B1 ESCO2 TAF6L TNKS TP53BP1 PHF13	4.99e-06	564	228	20	GO:0051052
GeneOntologyBiologicalProcess	microtubule-based process	KIF1B APC2 NCKAP5 DCTN1 CNTROB KIF24 AXIN1 CEP68 BRCA1 ATXN7 FBXW5 ARHGAP21 MOS FOXJ1 DNHD1 KIF26B TACC2 SPECC1L DNAH7 CLIP4 ARHGEF1 AP3B2 CABS1 MACF1 TNKS CEP295 ATP1A4 DNAAF1 SON	6.18e-06	1058	228	29	GO:0007017
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	APC2 NCKAP5 DCTN1 CNTROB KIF24 AXIN1 CEP68 BRCA1 ATXN7 FBXW5 MOS FOXJ1 TACC2 SPECC1L DNAH7 CLIP4 ARHGEF1 TNKS CEP295 DNAAF1 SON	5.33e-05	720	228	21	GO:0000226
GeneOntologyBiologicalProcess	regulation of DNA repair	RTEL1 BCL7B TMEM161A BRCA1 ATXN7 HSF1 FOXM1 WRAP53 TAF6L TP53BP1 PHF13	6.23e-05	234	228	11	GO:0006282
GeneOntologyBiologicalProcess	microtubule depolymerization	APC2 NCKAP5 KIF24 ATXN7 SPECC1L ARHGEF1	8.92e-05	66	228	6	GO:0007019
GeneOntologyBiologicalProcess	positive regulation of DNA metabolic process	RTEL1 BCL7B PAGR1 JUN TMEM161A BRCA1 GLI2 FGFR4 HSF1 FOXM1 WRAP53 TNKS TP53BP1	9.14e-05	333	228	13	GO:0051054
GeneOntologyCellularComponent	parallel fiber to Purkinje cell synapse	SPTBN2 PICALM GRID2IP SNAP91 PCLO	1.06e-04	43	230	5	GO:0098688
Domain	PH	PSD KIF1B SPTBN2 IQSEC1 ARHGAP21 PHLDB3 IQSEC3 RASGRF2 ARHGEF12 SH2B1 ARHGEF40 ARHGEF1 ARHGAP27 SNTB1	9.09e-06	278	229	14	SM00233
Domain	PH_DOMAIN	PSD KIF1B SPTBN2 IQSEC1 ARHGAP21 PHLDB3 IQSEC3 RASGRF2 ARHGEF12 SH2B1 ARHGEF40 ARHGEF1 ARHGAP27 SNTB1	9.47e-06	279	229	14	PS50003
Domain	PH_domain	PSD KIF1B SPTBN2 IQSEC1 ARHGAP21 PHLDB3 IQSEC3 RASGRF2 ARHGEF12 SH2B1 ARHGEF40 ARHGEF1 ARHGAP27 SNTB1	9.86e-06	280	229	14	IPR001849
Domain	PH_dom-like	PSD NBEAL1 KIF1B SPTBN2 DAB1 DAB2 IQSEC1 ARHGAP21 PHLDB3 IQSEC3 RASGRF2 ARHGEF12 SH2B1 ARHGEF40 ARHGEF1 ARHGAP27 SNTB1	2.15e-05	426	229	17	IPR011993
Domain	-	PSD KIF1B SPTBN2 DAB1 DAB2 IQSEC1 ARHGAP21 PHLDB3 IQSEC3 RASGRF2 ARHGEF12 SH2B1 ARHGEF40 ARHGEF1 ARHGAP27 SNTB1	2.78e-05	391	229	16	2.30.29.30
Domain	N-SET	SETD1A SETD1B	1.50e-04	2	229	2	PF11764
Domain	Clathrin_AP_2	PICALM SNAP91	1.50e-04	2	229	2	IPR014712
Domain	N-SET	SETD1A SETD1B	1.50e-04	2	229	2	SM01291
Domain	Rav1p_C	DMXL1 DMXL2	1.50e-04	2	229	2	IPR022033
Domain	COMPASS_Set1_N-SET	SETD1A SETD1B	1.50e-04	2	229	2	IPR024657
Domain	-	PICALM SNAP91	1.50e-04	2	229	2	1.20.58.150
Domain	Rav1p_C	DMXL1 DMXL2	1.50e-04	2	229	2	PF12234
Domain	RGS-like_dom	ARHGEF12 ARHGEF1	4.45e-04	3	229	2	IPR015212
Domain	RGS-like	ARHGEF12 ARHGEF1	4.45e-04	3	229	2	PF09128
Domain	IQSEC_PH	IQSEC1 IQSEC3	4.45e-04	3	229	2	IPR033742
Domain	IQ_SEC7_PH	IQSEC1 IQSEC3	4.45e-04	3	229	2	PF16453
Domain	PDZ	IL16 GRID2IP PDZD8 ARHGAP21 PCLO ARHGEF12 CASK SNTB1	5.59e-04	151	229	8	PS50106
Domain	PDZ	IL16 GRID2IP PDZD8 ARHGAP21 PCLO ARHGEF12 CASK SNTB1	5.84e-04	152	229	8	IPR001478
Domain	FH2	GRID2IP INF2 FHDC1	7.42e-04	15	229	3	PS51444
Domain	FH2_Formin	GRID2IP INF2 FHDC1	7.42e-04	15	229	3	IPR015425
Domain	FH2	GRID2IP INF2 FHDC1	7.42e-04	15	229	3	PF02181
Domain	-	PSD IQSEC1 IQSEC3	7.42e-04	15	229	3	1.10.1000.11
Domain	Sec7	PSD IQSEC1 IQSEC3	7.42e-04	15	229	3	PF01369
Domain	Sec7_alpha_orthog	PSD IQSEC1 IQSEC3	7.42e-04	15	229	3	IPR023394
Domain	FH2	GRID2IP INF2 FHDC1	7.42e-04	15	229	3	SM00498
Domain	ANTH_dom	PICALM SNAP91	8.84e-04	4	229	2	IPR011417
Domain	ANTH	PICALM SNAP91	8.84e-04	4	229	2	PF07651
Domain	SEC7	PSD IQSEC1 IQSEC3	9.05e-04	16	229	3	PS50190
Domain	Sec7	PSD IQSEC1 IQSEC3	9.05e-04	16	229	3	SM00222
Domain	Sec7_dom	PSD IQSEC1 IQSEC3	9.05e-04	16	229	3	IPR000904
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A ABCA2 PDE4A SETD1B PPRC1 TMEM94 SLC10A3 SRCAP ZZEF1 DCTN1 CNTROB GGT7 JUN URB1 TMEM132A LRRC56 PDZD8 ZNF579 HERC1 ARHGAP21 PHLDB3 DGCR2 FLNC FRAS1 HUWE1 WRAP53 SBNO2 PKMYT1 ARHGEF40 SLC12A4 INF2 ZNF335 PCNX1 DOT1L SNAPC4	2.53e-14	1105	233	35	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PDE4A SPTBN2 APC2 SRPK2 ZNF318 DCTN1 PICALM NCDN SNAP91 CAMKV ZBTB21 IQSEC1 ARHGAP21 IQSEC3 DMXL2 ANK2 ARHGEF12 DIDO1 SORBS1 SPECC1L HUWE1 GRM1 PAF1 CASK SEC23IP DCHS1 MACF1 TNKS TP53BP1	1.71e-11	963	233	29	28671696
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ABCA2 SPTBN2 NRXN2 TMEM132A SEMA6A TSPYL4 TTC28 KIAA1549 SORBS1 SH2B1 VPS13D MACF1	8.84e-11	130	233	12	12421765
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	IL16 WAPL PSD BCL7B SRPK2 ZNF318 SRCAP POLR1G ZZEF1 ANKRD54 HMG20A PASK ZNF469 BRCA1 ATXN7 ZBTB21 IQSEC1 ZNF579 TARBP2 TTC28 KIAA1549 RAB11FIP1 ARG2 TAF6L ARHGEF40 MACF1 ELF3 CEP295 PDCL SON	1.17e-10	1116	233	30	31753913
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B PPRC1 TMEM94 KIF1B CAMTA2 CSMD3 NCDN GRAMD1B ARHGAP21 IQSEC3 FRAS1 TTC28 ARHGEF12 R3HDM2 SORBS1 MACF1 AQR SON	3.84e-10	407	233	18	12693553
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	WAPL KIF1B DAB2 ZNF318 PAGR1 POLR1G PASK JUN ATXN7 ZBTB21 MKI67 IQSEC1 ZNF579 HSF1 FOXM1 DIDO1 HUWE1 MED1 WRAP53 ZNF335 SNAPC4 AKAP1 TP53BP1 SON	6.00e-10	774	233	24	15302935
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DAB2 PICALM AXIN1 PASK ARHGAP21 TTC28 KIF26B ARHGEF12 VPS13D EPHA2 MACF1 PDCL	2.03e-08	209	233	12	36779422
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	WAPL PPRC1 FANCD2OS ZNF318 CAMTA2 SRCAP DCTN1 NCDN URB1 MAP3K9 HERC1 ARHGAP21 DIDO1 TACC2 HUWE1 SBNO2 ESCO2 INF2 AOPEP ARHGEF1 RLIM MACF1 SLC35F2 CEP295 DOT1L TP53BP1	2.27e-08	1084	233	26	11544199
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	WAPL PSD PPRC1 MKI67 TRIM8 PDZD8 DMBT1 ARHGAP21 PNLIPRP1 TACC2 SORBS1 RET PPP1R3C PLXDC2 SEC23IP ANKRD30A	2.56e-08	415	233	16	16385451
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DENND2A IL16 LRRC49 KIF1B SPTBN2 SRPK2 DCTN1 NCDN GRAMD1B NRXN2 SNAP91 CAMKV IQSEC1 CORO7 ARHGAP21 FLNC IQSEC3 DMXL2 ANK2 PCLO ARHGEF12 KIAA1549 SORBS1 SPECC1L GRM1 CASK INF2 ARHGEF1 AP3B2 MACF1	3.56e-08	1431	233	30	37142655
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCHS2 ABCA2 WAPL PPRC1 KIF1B SPTBN2 APC2 SRPK2 NCKAP5 DCTN1 ANKRD54 HMG20A TRIM8 PDZD8 ARHGAP21 DMXL2 ANK2 TTC28 SORBS1 HUWE1 WRAP53 SH2B1 CASK ARG2 CLIP4 SEC23IP MACF1 TNKS	4.78e-08	1285	233	28	35914814
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	TMEM94 LRRC49 PICALM SEMA6A ARHGAP21 EHBP1 PHLDB3 RAB11FIP1 CASK LSR INF2 EPHA2 SEC23IP MACF1 SNTB1	1.95e-07	421	233	15	36976175
Pubmed	A human MAP kinase interactome.	SPTBN2 DAB2 NCKAP5 DCTN1 JUN CDC42EP2 EHBP1 FLNC KIF26B FOS SORBS1 MUC12 SPECC1L USF3 ARHGEF1 MACF1	2.20e-07	486	233	16	20936779
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	KIF1B DAB1 PICALM GRAMD1B SNAP91 MKI67 ARHGAP21 SORBS1 MACF1	2.22e-07	128	233	9	30995482
Pubmed	A census of human transcription factors: function, expression and evolution.	IRX5 FOXQ1 CAMTA2 HOXB2 JUN GLI2 CREB3L3 HSF1 FOXJ1 FOXM1 TFEC FOS KIAA1549 PPARG RFX2 ZFPM2 USF3 EGR3 ZNF335 NCOA1 ELF3 SNAPC4	2.46e-07	908	233	22	19274049
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SPTBN2 SRPK2 DCTN1 NCDN DMXL1 GRAMD1B PASK URB1 PDZD8 SEMA6A TARBP2 DGCR2 DMXL2 FRAS1 ANK2 KIAA1549 RAB11FIP1 PAF1 CASK PKMYT1 LSR INF2 EPHA2 MACF1 PDCL AKAP1 SNTB1 AQR TP53BP1	2.78e-07	1487	233	29	33957083
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	KIF1B DCTN1 ARHGAP21 FLNC DMXL2 ANK2 RASGRF2 ZNF407 PPHLN1 SORBS1 PAF1 CLIP4 MACF1 TNKS AKAP1 SON	2.97e-07	497	233	16	23414517
Pubmed	Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits.	JUN FOS NCOA1	2.97e-07	3	233	3	9642216
Pubmed	Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse.	PPARG MED1 NCOA1	2.97e-07	3	233	3	9708794
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	RTEL1 ADGRV1 CEP68 PASK URB1 NRXN2 PRUNE2 DMXL2 TTC28 MACF1 PCNX1	4.01e-07	225	233	11	12168954
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF1B MEX3C FAM117A ZBTB21 IQSEC1 MAP3K9 ARHGAP21 EHBP1 TTC28 KIF26B SORBS1 RAB11FIP1 DNAH7 LSR VPS13D ARHGEF1 MACF1 PDCL AKAP1 AQR OTOG	4.21e-07	861	233	21	36931259
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	SPTBN2 NCDN IQSEC1 MAP3K9 IQSEC3 DMXL2 ANK2 PCLO SORBS1 SPECC1L GRM1 MACF1	5.04e-07	281	233	12	28706196
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SETD1A SPTBN2 SRCAP PRUNE2 ARHGEF12 DIDO1 SPECC1L HUWE1	5.33e-07	104	233	8	9205841
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	IL16 NBEAL1 ZNF318 POLR1G PICALM ZBTB21 ZNF579 TARBP2 DMXL2 KIF26B PAF1 CLIP4 LSR INF2 ZNF335 RLIM OTOG SEZ6	1.11e-06	689	233	18	36543142
Pubmed	The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.	APC2 AXIN1 TNKS	1.18e-06	4	233	3	27068743
Pubmed	Three amino acids specify coactivator choice by retinoid X receptors.	PPARG MED1 NCOA1	1.18e-06	4	233	3	10935544
Pubmed	Human transcription factor protein interaction networks.	SETD1A FOXQ1 LRRC49 BCL7B ZNF318 PAGR1 SRCAP HMG20A JUN BRCA1 ATXN7 GLI2 ZBTB21 MKI67 HERC1 FOS DIDO1 R3HDM2 PPARG ZFPM2 TAF6L RLIM NCOA1 ELF3 DOT1L SNTB1 TP53BP1	1.35e-06	1429	233	27	35140242
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RTEL1 SPTBN2 CEP68 FAT2 TMEM132A PRUNE2 EHBP1 DMXL2 ZNF407 USP37 SH2B1 VPS13D USF3 MACF1 FHDC1	1.41e-06	493	233	15	15368895
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ZNF318 PICALM AXIN1 MKI67 ARHGAP21 EHBP1 TTC28 KIAA1549 EPHA2 SEC23IP MACF1	1.85e-06	263	233	11	34702444
Pubmed	LncRNAs in the Dlk1-Dio3 Domain Are Essential for Mid-Embryonic Heart Development.	JUN GLI2 MKI67 FOS	2.53e-06	15	233	4	39125754
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RTEL1 KIF1B DAB1 SRPK2 ATP9B ADGRV1 NCDN ATXN7 GLI2 ANKIB1 SEMA6A PRUNE2 EHBP1 PPHLN1 HUWE1 TMEM255B SH2B1 SBNO2 CASK ZBTB46 USF3 PLXDC2 INF2 AOPEP MACF1 SLC35F2 BSCL2	2.92e-06	1489	233	27	28611215
Pubmed	Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.	PPARG MED1 NCOA1	2.94e-06	5	233	3	17011503
Pubmed	A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.	PPARG MED1 NCOA1	2.94e-06	5	233	3	15026545
Pubmed	Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators.	PPARG MED1 NCOA1	2.94e-06	5	233	3	22070604
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	SETD1A SETD1B PAGR1 PPARG	3.35e-06	16	233	4	24368734
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	NBEAL1 DAB2 PICALM DMXL1 TMEM161A SNAP91 PRUNE2 DMXL2 TACC2 RAB11FIP1 AP3B2	4.01e-06	285	233	11	34369648
Pubmed	Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones.	GGT7 DNHD1 ARHGEF40 DOT1L	4.36e-06	17	233	4	12693554
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	ELP5 AXIN1 ATXN7 MKI67 IQSEC1 ANKIB1 HSF1 DNAH7 NCOA1 CEP295	4.36e-06	233	233	10	37704626
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SETD1A WAPL SPTBN2 ZNF318 SRCAP DCTN1 TTC28 DIDO1 SPECC1L HUWE1 MED1 PAF1 SEC23IP DOT1L TP53BP1	5.22e-06	549	233	15	38280479
Pubmed	Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.	DCHS2 FAT2 MKI67 DCHS1	5.58e-06	18	233	4	33108146
Pubmed	Changes in protooncogene expression correlated with general and sex-specific differentiation in murine primordial germ cells.	JUN MOS FOS	5.85e-06	6	233	3	8369223
Pubmed	Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.	PPARG MED1 NCOA1	5.85e-06	6	233	3	11027271
Pubmed	Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation.	JUN FOS NCOA1	5.85e-06	6	233	3	10497212
Pubmed	The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis.	PPARG MED1 NCOA1	5.85e-06	6	233	3	17468099
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	DCTN1 JUN ANKIB1 ARHGAP21 CABP1 ANK2 FOS PPARG TP53BP1	6.24e-06	191	233	9	20195357
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PPRC1 KIF1B NCDN CEP68 URB1 PCLO AQR	7.22e-06	105	233	7	9628581
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SETD1A APC2 DAB2 PICALM ZNF469 GLI2 PRUNE2 RET GRM1 SH2B1 USF3 TNKS SON	7.71e-06	430	233	13	35044719
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TMEM94 SPTBN2 CDC42EP2 SEMA6A ARHGAP21 EHBP1 ANK2 KIAA1549 RAB11FIP1 CASK LSR SLC12A4 EPHA2 SLC35F2 SNTB1	7.99e-06	569	233	15	30639242
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	JUN PPARG MED1 NCOA1	8.74e-06	20	233	4	11877444
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF318 SRCAP HMG20A JUN ZBTB21 CREB3L3 HSF1 FOXM1 FOS DIDO1 PAF1 RFX2 ZBTB46 LSR NCOA1 ELF3 SNAPC4 PHF13	9.99e-06	808	233	18	20412781
Pubmed	S 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects.	PPARG MED1 NCOA1	1.02e-05	7	233	3	17704298
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	DCHS2 FAT2 DCHS1	1.02e-05	7	233	3	16059920
Pubmed	Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings.	PPARG MED1 NCOA1	1.02e-05	7	233	3	21478865
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	AAMP DMXL1 FLNC HUWE1 MACF1 SON	1.25e-05	76	233	6	27542412
Pubmed	Loss of zinc-finger protein 212 leads to Purkinje cell death and locomotive abnormalities with phospholipase D3 downregulation.	SPTBN2 DAB1 FAT2 ATXN7 GRM1	1.42e-05	46	233	5	34815492
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1A DENND2A ABCA2 WAPL ADGRV1 ZZEF1 PASK NRXN2 ZBTB21 ANKIB1 DGCR2 KIAA1549 DIDO1 PCNX1	1.54e-05	529	233	14	14621295
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	PPARG MED1 NCOA1	1.62e-05	8	233	3	23178929
Pubmed	Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium.	GLI2 MKI67 PPARG ELF3	1.88e-05	24	233	4	21803035
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	WAPL ZNF318 SRCAP DCTN1 PICALM ZBTB21 MKI67 ARHGAP21 EHBP1 ANK2 DIDO1 TACC2 MED1 PAF1 SEC23IP MACF1 AKAP1 TP53BP1 SON	1.99e-05	934	233	19	33916271
Pubmed	The protein interaction landscape of the human CMGC kinase group.	TMEM94 SRPK2 AXIN1 PASK JUN FAM117A MED22 DMBT1 FOS DIDO1 PPHLN1 HUWE1 MED1 CASK PKMYT1 SON	2.12e-05	695	233	16	23602568
Pubmed	Mechanosensitive mTORC1 signaling maintains lymphatic valves.	MKI67 FLT4 ESCO2	2.42e-05	9	233	3	37036444
Pubmed	Spatiotemporal Gradient of Cortical Neuron Death Contributes to Microcephaly in Knock-In Mouse Model of Ligase 4 Syndrome.	BRCA1 MKI67 TP53BP1	2.42e-05	9	233	3	31541646
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	AAMP DAB2 PAGR1 CNTROB PICALM NCDN ANKRD54 AXIN1 MEX3C PASK FBXW5 IQSEC1 ARHGAP21 EHBP1 RAB11FIP1 PAF1 ARHGEF1 SEC23IP TNKS PDCL	2.60e-05	1038	233	20	26673895
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	KIF1B ZNF318 MEX3C JUN BRCA1 GLI2 MKI67 TRIM8 FOXM1 FOS DIDO1 TACC2 LSR NCOA1 MACF1 ELF3	2.69e-05	709	233	16	22988430
Pubmed	Human CIA2A-FAM96A and CIA2B-FAM96B integrate iron homeostasis and maturation of different subsets of cytosolic-nuclear iron-sulfur proteins.	ELP5 RTEL1 IREB2 GGT7 PAF1 SON	3.10e-05	89	233	6	23891004
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	DCTN1 TMEM161A PPARG MED1 NCOA1 MACF1 PDCL	3.37e-05	133	233	7	15604093
Pubmed	Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.	JUN FOS PPARG	3.44e-05	10	233	3	24411941
Pubmed	A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.	BRCA1 HUWE1 MED1	3.44e-05	10	233	3	17478428
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	SPTBN2 MKI67 ANK2	3.44e-05	10	233	3	22159418
Pubmed	Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.	PPARG MED1 NCOA1	3.44e-05	10	233	3	30595551
Pubmed	53BP1, a mediator of the DNA damage checkpoint.	BRCA1 TP53BP1	4.47e-05	2	233	2	12364621
Pubmed	Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential.	ARHGEF12 ARHGEF1	4.47e-05	2	233	2	14712228
Pubmed	KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2.	KLF14 IREB2	4.47e-05	2	233	2	36600258
Pubmed	HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.	BRCA1 HUWE1	4.47e-05	2	233	2	24342616
Pubmed	Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells.	JUN FOS	4.47e-05	2	233	2	9443941
Pubmed	Replicated chromatin curtails 53BP1 recruitment in BRCA1-proficient and BRCA1-deficient cells.	BRCA1 TP53BP1	4.47e-05	2	233	2	33811064
Pubmed	Distinct synaptic localization patterns of brefeldin A-resistant guanine nucleotide exchange factors BRAG2 and BRAG3 in the mouse retina.	IQSEC1 IQSEC3	4.47e-05	2	233	2	22886754
Pubmed	Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy.	JUN ATXN7	4.47e-05	2	233	2	17189700
Pubmed	Molecular regulation of PPARγ/RXRα signaling by the novel cofactor ZFP407.	ZNF407 PPARG	4.47e-05	2	233	2	38781157
Pubmed	Lack of seipin in neurons results in anxiety- and depression-like behaviors via down regulation of PPARγ.	PPARG BSCL2	4.47e-05	2	233	2	24651066
Pubmed	Seipin knockout in mice impairs stem cell proliferation and progenitor cell differentiation in the adult hippocampal dentate gyrus via reduced levels of PPARγ.	PPARG BSCL2	4.47e-05	2	233	2	26398946
Pubmed	c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling.	JUN RET	4.47e-05	2	233	2	22753894
Pubmed	Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts.	JUN FOS	4.47e-05	2	233	2	12547826
Pubmed	Genome-wide studies highlight indirect links between human replication origins and gene regulation.	JUN FOS	4.47e-05	2	233	2	18838675
Pubmed	The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.	PPARG NCOA1	4.47e-05	2	233	2	20717101
Pubmed	Ap-1 recognizes sequence elements on hiv-1 LTR in human epithelial tumor-cell lines.	JUN FOS	4.47e-05	2	233	2	21607373
Pubmed	A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma.	PPARG ELF3	4.47e-05	2	233	2	33402390
Pubmed	Molecular cloning of c-jun and c-fos cDNAs from porcine anterior pituitary and their involvement in gonadotropin-releasing hormone stimulation.	JUN FOS	4.47e-05	2	233	2	8793856
Pubmed	BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.	BRCA1 TP53BP1	4.47e-05	2	233	2	30257212
Pubmed	Tankyrase-1 Ankyrin Repeats Form an Adaptable Binding Platform for Targets of ADP-Ribose Modification.	AXIN1 TNKS	4.47e-05	2	233	2	27594684
Pubmed	Peroxisome proliferator-activated receptors, coactivators, and downstream targets.	PPARG NCOA1	4.47e-05	2	233	2	11330046
Pubmed	Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome.	MKI67 RET	4.47e-05	2	233	2	27543214
Pubmed	Characterization of the transduction pathway involved in c-fos and c-jun expression induced by Aggregatibacter actinomycetemcomitans lipopolysaccharides in human gingival fibroblasts.	JUN FOS	4.47e-05	2	233	2	18621151
Pubmed	HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.	BRCA1 HUWE1	4.47e-05	2	233	2	24472556
Pubmed	Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen.	JUN FOS	4.47e-05	2	233	2	12692226
Pubmed	AP-1 is a regulatory transcription factor of inflammaging in the murine kidney and liver.	JUN FOS	4.47e-05	2	233	2	37154113
Pubmed	BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair.	BRCA1 TP53BP1	4.47e-05	2	233	2	22553214
Pubmed	Differential induction of the two early genes c-jun and c-fos in weakly and strongly metastatic murine lymphoma cell lines.	JUN FOS	4.47e-05	2	233	2	8150544
Pubmed	LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN/c-FOS in human acute myeloid leukemia cells.	JUN FOS	4.47e-05	2	233	2	27102414
Pubmed	The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2/seipin plays a key role in adipocyte differentiation.	PPARG BSCL2	4.47e-05	2	233	2	19574402
Interaction	NCOA6 interactions	SETD1A SETD1B IREB2 PAGR1 JUN MKI67 HSF1 FOS PPARG MED1 ZNF335 NCOA1 TP53BP1	1.21e-08	145	230	13	int:NCOA6
Interaction	TOP3B interactions	SETD1A ABCA2 PDE4A SETD1B RTEL1 PPRC1 TMEM94 KIF1B SPTBN2 IREB2 SLC10A3 SRCAP ZZEF1 DCTN1 CNTROB GGT7 JUN URB1 TMEM132A LRRC56 PDZD8 ZNF579 HERC1 ARHGAP21 PHLDB3 DGCR2 FLNC FRAS1 R3HDM2 HUWE1 WRAP53 SBNO2 PKMYT1 ARHGEF40 SLC12A4 INF2 ZNF335 PCNX1 DOT1L SNAPC4 TP53BP1	8.25e-08	1470	230	41	int:TOP3B
Interaction	SNTB1 interactions	INSYN1 HMG20A ADRA1D FGFR4 FLT4 CASK EPHA2 SNTB1	5.75e-07	63	230	8	int:SNTB1
Interaction	TNIK interactions	INSYN1 SPTBN2 SNAP91 CAMKV IQSEC1 FGFR4 ARHGAP21 IQSEC3 ANK2 HUWE1 PAF1 CASK EPHA2 DCHS1 MACF1 TNKS TP53BP1	1.96e-06	381	230	17	int:TNIK
Interaction	DIRAS3 interactions	LRRC49 KIF1B SPTBN2 PICALM MAP3K9 FGFR4 HERC1 ARHGAP21 KIAA1549 HUWE1 LSR SLC12A4 EPHA2 MACF1	2.04e-06	262	230	14	int:DIRAS3
Interaction	TBP interactions	POLR1G JUN ATXN7 GLI2 HSF1 FOXJ1 FOS DCAF8L2 HUWE1 MED1 NCOA1 ELF3 SNAPC4	7.26e-06	253	230	13	int:TBP
Interaction	YWHAH interactions	ABCA2 KIF1B DCTN1 MEX3C JUN FAM117A GRID2IP ZBTB21 MAP3K9 HERC1 ARHGAP21 EHBP1 TTC28 KIF26B PPHLN1 R3HDM2 SORBS1 SPECC1L HUWE1 MED1 RAB11FIP1 DNAH7 LSR VPS13D NCOA1 MACF1 PDCL AKAP1 AQR OTOG	9.02e-06	1102	230	30	int:YWHAH
Interaction	NUP155 interactions	NBEAL1 LRRC49 DAB2 GRAMD1B BRCA1 PDZD8 FGFR4 EHBP1 FLT4 TACC2 HUWE1 RET PKMYT1 VPS13D INF2 EPHA2 SEC23IP AKAP1	1.00e-05	477	230	18	int:NUP155
Interaction	C2CD4B interactions	ADGRV1 PASK HERC1 TARBP2 FRAS1 MACF1	1.02e-05	44	230	6	int:C2CD4B
Interaction	CYFIP1 interactions	PDE4A SPTBN2 DCTN1 PICALM NCDN SNAP91 CAMKV IQSEC1 ANK2 RET EPHA2 ARHGEF1 MACF1 DOT1L	1.09e-05	303	230	14	int:CYFIP1
Interaction	ASH2L interactions	SETD1A FOXQ1 SETD1B PAGR1 SRCAP PICALM BRCA1 MKI67 FOS PPARG ZNF335 DOT1L TP53BP1	1.19e-05	265	230	13	int:ASH2L
Interaction	KALRN interactions	SPTBN2 ATXN7 IQSEC1 MAP3K9 ANK2 SORBS1 SPECC1L MACF1	1.43e-05	96	230	8	int:KALRN
Interaction	GTF3C4 interactions	FOXQ1 SRPK2 POLR1G PASK BRCA1 HSF1 FOXM1 HUWE1 USP37 DOT1L TP53BP1	1.56e-05	195	230	11	int:GTF3C4
Interaction	OR4N2 interactions	ABCA2 TMEM94 SLC12A9 AMFR SLC12A4	1.76e-05	29	230	5	int:OR4N2
Interaction	FLOT1 interactions	LRRC49 SPTBN2 PICALM ARHGAP21 EHBP1 ANK2 PCLO ARHGEF12 KIAA1549 SORBS1 RAB11FIP1 CASK LSR SLC12A4 EPHA2 MACF1 DOT1L	3.47e-05	475	230	17	int:FLOT1
Interaction	CDK6 interactions	DAB1 FGFR4 DMBT1 HSF1 FOXM1 KIF26B PPHLN1 SORBS1 GRM1 EPHA2 ZNF335	3.85e-05	215	230	11	int:CDK6
Interaction	MAPRE3 interactions	KIF1B APC2 NCKAP5 DCTN1 KIF24 JUN ARHGAP21 TTC28 TACC2 SPECC1L MACF1	7.08e-05	230	230	11	int:MAPRE3
Interaction	PLK1 interactions	WAPL DCTN1 CNTROB KIF24 PASK BRCA1 TRIM8 HSF1 TARBP2 FOXJ1 FOXM1 DNHD1 MED1 USP37 PKMYT1 AKAP1 TP53BP1	8.34e-05	510	230	17	int:PLK1
Interaction	ADRA1D interactions	ADRA1D AMFR FLNC SNTB1	8.49e-05	21	230	4	int:ADRA1D
Interaction	CARM1 interactions	ATG4A NCKAP5 SRCAP AXIN1 MDP1 BRCA1 GLI2 FOS SEC23IP NCOA1 DOT1L SNTB1 TP53BP1	9.83e-05	325	230	13	int:CARM1
Cytoband	1p32-p31	DAB1 JUN MACF1	1.06e-05	9	233	3	1p32-p31
GeneFamily	Cadherin related	DCHS2 FAT2 RET DCHS1	1.02e-05	17	151	4	24
GeneFamily	PDZ domain containing	IL16 GRID2IP PDZD8 ARHGAP21 PCLO ARHGEF12 CASK SNTB1	4.18e-05	152	151	8	1220
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PSD KIF1B SPTBN2 ARHGAP21 PHLDB3 RASGRF2 SH2B1 ARHGAP27 SNTB1	5.94e-05	206	151	9	682
GeneFamily	WD repeat domain containing	AAMP NBEAL1 DMXL1 FBXW5 HERC1 CORO7 DMXL2 DCAF8L2 WRAP53	3.62e-04	262	151	9	362
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	AXIN1 BRCA1 MKI67 GRM1 PKMYT1 PPP1R3C AKAP1	8.25e-04	181	151	7	694
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASGRF2 ARHGEF12 ARHGEF40 ARHGEF1	2.26e-03	66	151	4	722
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1A SETD1B DOT1L	2.83e-03	34	151	3	487
Coexpression	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP	SLC10A3 AXIN1 CEP68 HERC1 R3HDM2 PTPRU EPHA2 ZNF335 MACF1 ELF3 ARHGAP45 SON	2.31e-07	198	233	12	M5580
Coexpression	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	DENND2A GBP6 CAMTA2 DCTN1 IQSEC1 ZNF579 RASGRF2 KIF26B PLXDC2 EGR3 SON	1.83e-06	199	233	11	M7451
Coexpression	GSE30083_SP2_VS_SP4_THYMOCYTE_UP	SPTBN2 KLF14 NALCN MED22 TMEM132A ANK2 KIF26B TACC2 PKMYT1 ELF3 AKAP1	1.92e-06	200	233	11	M5034
Coexpression	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP	DENND2A PADI4 SLC12A9 IQSEC1 HERC1 CORO7 RASGRF2 FOS DIDO1 TACC2	4.94e-06	179	233	10	M8828
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	NCKAP5 GRAMD1B ANKIB1 PRUNE2 EHBP1 FRAS1 ANK2 TTC28 PCLO PLXDC2 AOPEP	5.04e-06	221	233	11	M39222
Coexpression	ZHONG_PFC_C3_MICROGLIA	ABCA2 LRRC49 KIF1B APC2 CSMD3 NCDN NRXN2 SNAP91 CAMKV TMEM132A ANK2 PCLO PPHLN1 TACC2 AP3B2 NCOA1	8.61e-06	488	233	16	M39104
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	EVI2B CEP68 PASK FAM117A TSPYL4 ARHGAP21 TTC28 USF3 PCNX1 PDCL	1.05e-05	195	233	10	M4195
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	PDE4A IRX5 FOXQ1 DAB2 ADGRV1 STAC2 ADRA1D GRID2IP GLI2 FOXJ1 RASGRF2 KIF26B RET PTPRU RAB11FIP1 ARG2 SLCO5A1 SLC12A4 EGR3 EPHA2 CPXM1 FHDC1 ARHGAP27 SNTB1	3.45e-05	1074	233	24	M1941
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	WAPL KIF1B PICALM NCDN JUN ATXN7 FAM76A MKI67 TRIM8 IQSEC1 PDZD8 ARHGEF12 SORBS1 TAF6L VPS13D SEC23IP MACF1 SLC35F2 CEP295 PHF13	3.91e-05	807	233	20	M14594
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	PSD RTEL1 PAGR1 ULBP3 CNTROB PASK SNAP91 TMEM132A MKI67 SGO2 FOXM1 EHBP1 USP37 PKMYT1 AP3B2 DOT1L TP53BP1 SEZ6	4.15e-05	680	233	18	MM456
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	PDE4A MAP3K9 KIF26B PTPRU ARG2 INF2 EPHA2 SLC35F2	4.39e-05	143	233	8	M1935
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	PDE4A MAP3K9 KIF26B PTPRU ARG2 INF2 EPHA2 SLC35F2	4.39e-05	143	233	8	MM819
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	PSD LRRC49 APC2 ZNF318 CSMD3 NCDN FAT2 NRXN2 NALCN SNAP91 ANKIB1 MAP3K9 HERC1 TSPYL4 ANK2 PCLO ARHGEF12 KIAA1549 SORBS1 GRM1 ZFPM2 CASK AP3B2 TNKS	5.47e-05	1106	233	24	M39071
Coexpression	CHASSOT_SKIN_WOUND	JUN FOS EGR3	5.60e-05	9	233	3	M13038
Coexpression	NUYTTEN_NIPP1_TARGETS_DN	DENND2A AAMP PDE4A FOXQ1 MKI67 TRIM8 IQSEC1 PDZD8 FOXM1 AMFR HUWE1 MED1 USP37 LSR USF3 INF2 EPHA2 NCOA1 ELF3 PDCL	7.35e-05	845	233	20	M18090
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP	DENND2A CEP68 ATXN7 IQSEC1 HERC1 R3HDM2 SH2B1 VPS13D ARHGEF1	7.73e-05	199	233	9	M4521
Coexpression	GSE360_DC_VS_MAC_L_MAJOR_DN	KIF1B DMXL1 BRCA1 TARBP2 FOXM1 DGCR2 FLT4 TTC28 FOS	7.73e-05	199	233	9	M5182
Coexpression	GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN	SETD1A RTEL1 IREB2 SRCAP AXIN1 C2 PAF1 NCOA1 AQR	8.04e-05	200	233	9	M3377
Coexpression	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP	PADI4 ELP5 FAM117A LMF2 BRCA1 FOXM1 LSR SLC12A4 PDCL	8.04e-05	200	233	9	M5992
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	WAPL SRPK2 ZZEF1 PICALM HOXB2 JUN BRCA1 EHBP1 DMXL2 TTC28 R3HDM2 SPECC1L MED1 CASK NCOA1 MACF1 TNKS AQR TP53BP1 SON	8.76e-05	856	233	20	M4500
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP	IL16 ZNF318 MEX3C CEP68 JUN FAM117A FOXM1 EHBP1 SPECC1L HUWE1 DNAH7 TNKS AKAP1 AQR	9.90e-05	475	233	14	M40979
Coexpression	GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	RTEL1 PPRC1 MKI67 PAF1 ZFPM2 SLC12A4 DOT1L SNAPC4	1.30e-04	167	233	8	M9116
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KIF24 BRCA1 PROSER3 ZBTB21 SGO2 SEMA6A FOXJ1 KIAA1549 MUC12 DNAH7 CEP295	5.47e-09	190	233	11	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	NBEAL1 KIF1B IREB2 ADGRV1 HUWE1 MED1 USP37 USF3 PCNX1 AQR SON	6.44e-09	193	233	11	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXQ1 ADGRV1 GGT7 HOXB2 TMEM132A MKI67 SGO2 PKMYT1 ESCO2 CEP295	2.94e-08	174	233	10	7b2f35add804981c7d588a996bdbca6ec11a1ca5
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	WAPL NBEAL1 ZNF318 DCTN1 ATXN7 SELENOO FBXW5 SGO2 DMXL2 AQR	4.98e-08	184	233	10	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	LPS-IL1RA-Myeloid_granulocytic-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IREB2 POLR1G GRAMD1B MAP3K9 TSPYL4 RAB11FIP1 RFX2 SLCO5A1 SLC35F2	1.27e-07	154	233	9	43735f7c58cac51855ded486ee8d8729a1b9909e
ToppCell	LPS-IL1RA-Myeloid_granulocytic\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IREB2 POLR1G GRAMD1B MAP3K9 TSPYL4 RAB11FIP1 RFX2 SLCO5A1 SLC35F2	1.27e-07	154	233	9	d55fb73461885e1e02061a344ff89624ef4de487
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	INSYN1 SPTBN2 DACT2 STAC2 MAP3K9 IQSEC3 RET GRM1 CLIP4	2.53e-07	167	233	9	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	INSYN1 SPTBN2 DACT2 STAC2 MAP3K9 IQSEC3 RET GRM1 CLIP4	2.53e-07	167	233	9	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SPTBN2 NALCN SNAP91 PRUNE2 ANK2 PCLO ARG2 SLCO5A1 AP3B2	3.09e-07	171	233	9	b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1\|TCGA-Adrenal / Sample_Type by Project: Shred V9	PRUNE2 FOS PCLO SORBS1 RET EGR3 AP3B2 BSCL2 SEZ6	4.54e-07	179	233	9	431e1b29015ec817f778499106d24b19cfc825ae
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXB2 STAC2 NRXN2 FLT4 PTPRU ZFPM2 ARHGEF40 CLEC14A ATP1A4	5.22e-07	182	233	9	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	NCKAP5 PICALM FLNC ANK2 ARHGEF12 TACC2 SORBS1 USP37 AOPEP	7.48e-07	190	233	9	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 BRCA1 MKI67 SGO2 FOXM1 TFEC DMXL2 PKMYT1 ESCO2	8.90e-07	194	233	9	effd38e51062b225ecabc7e1c50154e65495d559
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1B HERC1 TTC28 PCLO HUWE1 RET NCOA1 MACF1 SON	9.28e-07	195	233	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1B HERC1 TTC28 PCLO HUWE1 RET NCOA1 MACF1 SON	9.28e-07	195	233	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FANCD2OS KIF24 BRCA1 MKI67 SGO2 FOXM1 GINS4 PKMYT1 ESCO2	9.69e-07	196	233	9	1d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FANCD2OS KIF24 BRCA1 MKI67 SGO2 FOXM1 GINS4 PKMYT1 ESCO2	1.01e-06	197	233	9	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ADGRV1 BRCA1 MKI67 SGO2 FOXM1 GINS4 RFX2 PKMYT1 ESCO2	1.05e-06	198	233	9	dc0c6189ff9dd76675f63acf1cbc7dda60e75f3f
ToppCell	remission-Classical_Monocyte\|World / disease stage, cell group and cell class	EVI2B LILRA5 TFEC DMXL2 LILRB3 FOS RAB11FIP1 ARHGEF40 PLXDC2	1.05e-06	198	233	9	056b8745e753b1a500cf58d09a2ebf38707e1357
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ADGRV1 BRCA1 MKI67 SGO2 FOXM1 GINS4 RFX2 PKMYT1 ESCO2	1.05e-06	198	233	9	50f236ab7ef6f00721f6cd714e3eee183077beeb
ToppCell	VE-granulo2\|VE / Condition, Cell_class and T cell subcluster	CDC42EP2 C2 LILRA5 TFEC DMXL2 LILRB3 FOS PLXDC2 EGR3	1.10e-06	199	233	9	05b47fdc01eccee0eaf4c781eeff93c47fe0533e
ToppCell	VE-granulo2-\|VE / Condition, Cell_class and T cell subcluster	CDC42EP2 C2 LILRA5 TFEC DMXL2 LILRB3 FOS PLXDC2 EGR3	1.10e-06	199	233	9	455e92047201ddd0c29a437a838e5fa135de7995
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 MKI67 SGO2 SEMA6A FOXM1 GINS4 RFX2 PKMYT1 ESCO2	1.15e-06	200	233	9	31dd81df9aa754a1e69b905bf9b8ce73ff8175aa
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	BRCA1 MKI67 SGO2 SEMA6A FOXM1 GINS4 RFX2 PKMYT1 ESCO2	1.15e-06	200	233	9	54174a485a82480726fa06efa6e050ddea77cb3c
ToppCell	Parenchyma_Control_(B.)\|World / Sample group, Lineage and Cell type	DAB2 EVI2B IQSEC3 R3HDM2 PPARG RAB11FIP1 CLIP4 PLXDC2 SNTB1	1.15e-06	200	233	9	220b6e5f936b3d08b031d6cabc5793213b98b8e2
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	WAPL TMEM94 ZNF318 USF3 MACF1 PCNX1 CEP295 ARHGAP45	1.64e-06	155	233	8	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	DAB1 ANKRD30B CSMD3 NCDN ANK2 PCLO PCDHA2 RET	2.62e-06	165	233	8	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA1 MKI67 SGO2 FLT4 PCDHGA2 KIAA1549 ESCO2 TNKS	2.86e-06	167	233	8	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	LPS-IL1RA-Unknown-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPTBN2 NRXN2 SGO2 AMTN USP37 PKMYT1 SLCO5A1	2.95e-06	118	233	7	aefad0b35aff980b6a2a98057735442e8a65ab04
ToppCell	LPS-IL1RA-Unknown\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPTBN2 NRXN2 SGO2 AMTN USP37 PKMYT1 SLCO5A1	2.95e-06	118	233	7	6cb4063b83f867b782080ce5b1199b51bb277f2a
ToppCell	Control\|World / group, cell type (main and fine annotations)	NCKAP5 ADGRV1 DMBT1 FOS TACC2 RAB11FIP1 RFX2 ELF3	2.99e-06	168	233	8	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	Control-B_naive-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	WAPL TMEM94 ZNF318 USF3 MACF1 PCNX1 CEP295 ARHGAP45	3.41e-06	171	233	8	d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM94 GRID2IP HERC1 FOXM1 FRAS1 PCLO KIAA1549 PCNX1	3.88e-06	174	233	8	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	LPS-IL1RA-Unknown-Endothelial-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPTBN2 BRCA1 SGO2 AMTN USP37 PKMYT1 SLCO5A1	4.33e-06	125	233	7	2938a1d62afe1e0a3abba5eb92f07b886cc0accd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF24 BRCA1 MKI67 FOXM1 GINS4 PKMYT1 ESCO2 DOT1L	4.79e-06	179	233	8	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FANCD2OS KIF24 BRCA1 MKI67 SGO2 FOXM1 PKMYT1 ESCO2	4.99e-06	180	233	8	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FANCD2OS KIF24 BRCA1 MKI67 FOXM1 GINS4 PKMYT1 ESCO2	4.99e-06	180	233	8	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSYN1 LRRC49 GGT7 TMEM132A FOXJ1 FRAS1 KIF26B SLCO5A1	5.19e-06	181	233	8	7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCell	droplet-Liver-Npc-21m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXB2 STAC2 NRXN2 FLT4 PTPRU ARHGEF40 CLEC14A ATP1A4	5.41e-06	182	233	8	dc55de945c6f78f32eb3a1b3520835eb8417e068
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	5.41e-06	182	233	8	3dec003bad0f3716cf8163861a9d4302a7d6df8c
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXB2 STAC2 NRXN2 FLT4 PTPRU ARHGEF40 CLEC14A ATP1A4	5.41e-06	182	233	8	010a7364da46101cb5068891fd7bc712ea8f13bd
ToppCell	droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	5.63e-06	183	233	8	ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF24 STAC2 BRCA1 FOXM1 PRUNE2 TFEC PKMYT1 LSR	5.63e-06	183	233	8	42dc31d587fbb9724b2f0be5ee8ed77233f67b86
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2 MKI67 SGO2 LILRA5 FOXM1 PRUNE2 TACC2 ESCO2	5.63e-06	183	233	8	e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 FRAS1 KIF26B PCLO GRM1 ATP1A4 OTOG	5.86e-06	184	233	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 FRAS1 KIF26B PCLO GRM1 ATP1A4 OTOG	5.86e-06	184	233	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	DCHS2 SPTBN2 AXIN1 EHBP1 GDF15 CLIP4 SLC35F2 PHF13	5.86e-06	184	233	8	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative\|Bac-SEP / Disease, Lineage and Cell Type	DAB1 BRCA1 MKI67 SGO2 FOXM1 PKMYT1 ESCO2 CPXM1	5.86e-06	184	233	8	848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 FRAS1 KIF26B PCLO GRM1 ATP1A4 OTOG	5.86e-06	184	233	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	5.86e-06	184	233	8	8fa30789c9d583188667cf375d2218e392dd40bc
ToppCell	droplet-Lung-nan-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	5.86e-06	184	233	8	3261d767d5e3d9e9fbac22ad73ca14e44beed89c
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	6.10e-06	185	233	8	775b72319ef6acffd2c9a74293b9c1bccea33f42
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	FANCD2OS KIF24 BRCA1 MKI67 SGO2 FOXM1 PKMYT1 ESCO2	6.10e-06	185	233	8	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BRCA1 MKI67 SGO2 FOXM1 PRUNE2 TFEC ESCO2 LSR	6.10e-06	185	233	8	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	6.10e-06	185	233	8	afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	6.10e-06	185	233	8	4bee178ede12f56ba5f5bec44a03dc2a62c50137
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP6 DAB2 SELENOO FLT4 ZBTB46 ARHGEF40 CLEC14A DCHS1	6.10e-06	185	233	8	512a195ebbae445afe3722a3943020080daf2f3c
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IRX5 FANCD2OS BRCA1 MKI67 SGO2 FOXM1 PKMYT1 ESCO2	6.10e-06	185	233	8	9d424a8608b339dd6129c58d87626678d4ec4af7
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DENND2A GLI2 FLNC KIF26B TACC2 SORBS1 RFX2 AOPEP	6.10e-06	185	233	8	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	droplet-Lung-nan-18m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	6.60e-06	187	233	8	f0c6e53035b00772377c4d5f761b4d11026b911a
ToppCell	droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 IQSEC1 LILRA5 PRUNE2 TFEC DMXL2 PPARG LSR	6.60e-06	187	233	8	f20e7a1751694390f535ffb27b97e887220f8695
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD SPTBN2 NCDN ADRA1D NRXN2 CAMKV IQSEC3 PCLO	6.60e-06	187	233	8	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD SPTBN2 NCDN ADRA1D NRXN2 CAMKV IQSEC3 PCLO	6.60e-06	187	233	8	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSD SPTBN2 NCDN ADRA1D NRXN2 CAMKV IQSEC3 PCLO	6.60e-06	187	233	8	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIF24 PASK ADRA1D MKI67 SGO2 FOXM1 PKMYT1	6.86e-06	134	233	7	4d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCell	343B-Lymphocytic-ILC-ILC-1\|343B / Donor, Lineage, Cell class and subclass (all cells)	AXIN1 ZBTB21 CORO7 USF3 SLC12A4 EGR3 PCNX1 CEP295	6.86e-06	188	233	8	8f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA1 MKI67 SGO2 CREB3L3 FOXM1 GINS4 PKMYT1 ESCO2	6.86e-06	188	233	8	319fbeca200ab998daf49fcaee0bfdb57bf7ee4b
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN PRUNE2 ANK2 TTC28 FOS PCLO NCOA1 SON	6.86e-06	188	233	8	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN2 STAC2 FAT2 NRXN2 TMEM132A PRUNE2 PCLO GRM1	7.13e-06	189	233	8	f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IRX5 ADGRV1 FOXJ1 FRAS1 GDF15 PCLO CLIP4 ELF3	7.41e-06	190	233	8	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SEMA6A PRUNE2 FLT4 ANK2 PCLO RET RAB11FIP1 PLXDC2	7.41e-06	190	233	8	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A IL16 GLI2 FGFR4 FRAS1 ANK2 ZFPM2 MACF1	7.70e-06	191	233	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	MS-Treg-exh_CD4\|MS / Condition, Cell_class and T cell subcluster	DCTN1 SLC12A9 ARHGEF12 SPECC1L CASK INF2 MTRR AKAP1	8.00e-06	192	233	8	c6722bf142c84ccedd99c1a3344085aecb4cbab4
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SRPK2 NCKAP5 GRAMD1B FRAS1 TTC28 PLXDC2 AOPEP MACF1	8.00e-06	192	233	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KIF24 JUN BRCA1 SELENOO FOS GINS4 MACF1 PCNX1	8.00e-06	192	233	8	930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KIF24 JUN BRCA1 SELENOO FOS GINS4 MACF1 PCNX1	8.00e-06	192	233	8	c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A IL16 GLI2 FGFR4 FRAS1 ANK2 ZFPM2 MACF1	8.00e-06	192	233	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IRX5 ADGRV1 FRAS1 ANK2 GDF15 PCLO DNAH7 ELF3	8.00e-06	192	233	8	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN2 NRXN2 CAMKV CABP1 RASGRF2 PCLO GRM1 SEZ6	8.31e-06	193	233	8	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL16 SPTBN2 FAT2 NRXN2 TMEM132A PRUNE2 PCLO GRM1	8.31e-06	193	233	8	5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN2 NRXN2 CAMKV CABP1 RASGRF2 PCLO GRM1 SEZ6	8.31e-06	193	233	8	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTBN2 NRXN2 CAMKV CABP1 RASGRF2 PCLO GRM1 SEZ6	8.31e-06	193	233	8	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FANCD2OS KIF24 BRCA1 MKI67 SGO2 FOXM1 PKMYT1 ESCO2	8.63e-06	194	233	8	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	NCKAP5 CAMTA2 ZNF407 PPARG LSR CLEC14A ARHGAP27 TP53BP1	8.63e-06	194	233	8	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	NCKAP5 CAMTA2 ZNF407 PPARG LSR CLEC14A ARHGAP27 TP53BP1	8.63e-06	194	233	8	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1B JUN ANK2 TTC28 FOS HUWE1 LRRC55 SON	8.63e-06	194	233	8	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDC42EP2 FGFR4 PCDHA2 SPECC1L PPP1R3C PLXDC2 CPXM1 MACF1	8.96e-06	195	233	8	598b69032a8441a23749b27863d80f7a1fc82a96
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Lymphoid / Condition, Lineage and Cell class	BRCA1 MKI67 SGO2 FOXM1 LILRB3 PKMYT1 ESCO2 PLXDC2	8.96e-06	195	233	8	578bbb06a5476c08fc3b351cc580c551dfe53ae4
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2 BRCA1 MKI67 SGO2 FOXM1 DMXL2 PKMYT1 ESCO2	8.96e-06	195	233	8	c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)\|Adult / Lineage, Cell type, age group and donor	GRAMD1B IQSEC1 TFEC DMXL2 PPARG CLIP4 PLXDC2 SNTB1	8.96e-06	195	233	8	55e25f702af19146a161861cfd15f40bbda1dc35
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NBEAL1 DAB2 EVI2B TFEC FOS PPARG PLXDC2 SNTB1	8.96e-06	195	233	8	ec218ae03ebf8588996e86d6d9a8ea3cf71affaa
ToppCell	moderate-Myeloid\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DAB2 EVI2B LILRA5 LILRB3 FOS ARHGEF40 PLXDC2 EGR3	9.30e-06	196	233	8	76a4c615ea7594e99c1a938d6900a1b262cc09f5
ToppCell	proximal-Hematologic-Proliferating_Macrophage\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 MKI67 SGO2 CREB3L3 FOXM1 GINS4 PKMYT1 ESCO2	9.65e-06	197	233	8	0b1fa881abbfcc54b322fc27124db3f8947af016
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LILRA5 TFEC DMXL2 LILRB3 FOS RAB11FIP1 ARHGEF40 PLXDC2	9.65e-06	197	233	8	6e96a6c2576f52b72aeab1e41f47a0af05ff327a
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPTBN2 FAT2 TMEM132A MAP3K9 AMTN FRAS1 EPHA2 ELF3	9.65e-06	197	233	8	58d809ccb8cc4b1e76acf0b8f996cd0e2637290c
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPTBN2 FAT2 TMEM132A MAP3K9 AMTN FRAS1 EPHA2 ELF3	9.65e-06	197	233	8	751f19b00f92e1334f653b870d3f7c0c149ff41a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FANCD2OS KIF24 BRCA1 MKI67 SGO2 FOXM1 PKMYT1 ESCO2	9.65e-06	197	233	8	84ed777cdba569200a3ef1654d8a12f17fcfb7f1
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Basal_1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SPTBN2 FAT2 TMEM132A MAP3K9 AMTN FRAS1 EPHA2 ELF3	9.65e-06	197	233	8	2701864e49878c5f323f5133e2c4b0a5a7fff7f5
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LILRA5 TFEC DMXL2 LILRB3 FOS RAB11FIP1 ARHGEF40 PLXDC2	9.65e-06	197	233	8	a80be1081f3ed0aceea69a33be21bca6bc354472
ToppCell	proximal-3-Hematologic-Proliferating_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 MKI67 SGO2 CREB3L3 FOXM1 GINS4 PKMYT1 ESCO2	9.65e-06	197	233	8	0dd9058aa19d1268ebba9a65555870224b5a5978
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRX5 PPRC1 ZNF318 POLR1G CEP68 PASK MED22 CDC42EP2 AMFR PTPRU INF2 EGR3 AOPEP ELF3	1.14e-08	191	233	14	1008_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	IRX5 PPRC1 POLR1G CEP68 PASK JUN CDC42EP2 GDF15 RET EGR3 NCOA1 SNAPC4 DNAAF1	8.16e-08	189	233	13	1643_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRX5 PPRC1 POLR1G NCDN CEP68 PASK BRCA1 IQSEC1 CDC42EP2 RET PKMYT1 EGR3 ELF3	8.68e-08	190	233	13	1056_DN
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	IRX5 ZNF318 PAGR1 POLR1G BRCA1 SLC12A9 CDC42EP2 RET SBNO2 EGR3 AOPEP ELF3 SNAPC4	9.23e-08	191	233	13	5210_DN
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	ABCA2 ZNF318 FGFR4 RET PTPRU WRAP53 TAF6L INF2 MACF1 ELF3 DNAAF1 AKAP1	5.48e-07	187	233	12	1656_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TMEM94 LRRC49 ZNF318 AXIN1 CEP68 PASK JUN BRCA1 CDC42EP2 EGR3 AOPEP ELF3	6.13e-07	189	233	12	1005_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	IRX5 PPRC1 SLC10A3 NCDN CEP68 PASK BRCA1 INF2 EGR3 AOPEP SNAPC4 AKAP1	6.86e-07	191	233	12	1057_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	PPRC1 POLR1G PASK JUN BRCA1 CDC42EP2 GINS4 RET PTPRU EGR3 DNAAF1 AKAP1	7.67e-07	193	233	12	1653_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A	IREB2 CAMTA2 SRCAP NCDN PASK JUN FGFR4 GINS4 PPP1R3C PCNX1 PDCL DNAAF1	9.53e-07	197	233	12	3433_DN
Drug	Isoxicam [34552-84-6]; Down 200; 12uM; PC3; HT_HG-U133A	PDE4A AXIN1 URB1 MED22 FGFR4 DGCR2 GDF15 ARHGEF12 ARG2 LSR VPS13D INF2	1.12e-06	200	233	12	7268_DN
Drug	Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; PC3; HT_HG-U133A	SETD1A GRAMD1B HOXB2 FGFR4 DMBT1 HSF1 PRUNE2 TACC2 HUWE1 TAF6L PCNX1	2.50e-06	179	233	11	4619_UP
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A	PDE4A CEP68 JUN CDC42EP2 FGFR4 RET WRAP53 EGR3 MACF1 SNAPC4 DNAAF1	2.64e-06	180	233	11	5202_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRX5 POLR1G MEX3C CEP68 PASK CDC42EP2 RET EGR3 AOPEP ELF3 AKAP1	3.62e-06	186	233	11	1066_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ZNF318 PASK JUN BRCA1 MED22 CDC42EP2 GDF15 SH2B1 EGR3 AOPEP NCOA1	4.22e-06	189	233	11	1006_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	IRX5 SLC10A3 NCDN AXIN1 CEP68 JUN GDF15 RET EGR3 AOPEP DNAAF1	4.22e-06	189	233	11	1651_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	IRX5 ZNF318 CEP68 JUN FLT4 GDF15 PTPRU EGR3 AOPEP NCOA1 ELF3	4.67e-06	191	233	11	6944_DN
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	RTEL1 IREB2 SRCAP HOXB2 FGFR4 FLT4 RET TAF6L EGR3 SNAPC4 AKAP1	4.67e-06	191	233	11	5964_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	POLR1G CEP68 JUN SLC12A9 RET SBNO2 EGR3 AOPEP ELF3 SNAPC4 DNAAF1	5.16e-06	193	233	11	5215_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A	RTEL1 SRCAP POLR1G MKI67 CDC42EP2 DMXL2 MED1 ARG2 VPS13D BSCL2 ARHGAP45	5.43e-06	194	233	11	1822_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	CAMTA2 NCDN AXIN1 PASK JUN RET MED1 TAF6L EGR3 SNAPC4 AKAP1	5.70e-06	195	233	11	6979_DN
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; HL60; HT_HG-U133A	SETD1A PDE4A SRCAP ZZEF1 LMF2 AMFR SBNO2 NCOA1 BSCL2 AKAP1 SNTB1	6.28e-06	197	233	11	1309_UP
Drug	Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	RTEL1 TMEM94 NCDN AXIN1 CEP68 JUN SLC12A9 IQSEC1 TACC2 SH2B1 PCNX1	6.28e-06	197	233	11	2644_DN
Drug	Oxaprozin [21256-18-8]; Down 200; 13.6uM; PC3; HT_HG-U133A	SETD1A ZNF318 NCDN AXIN1 JUN URB1 MAP3K9 ARHGEF12 GRM1 SBNO2 CLIP4	6.28e-06	197	233	11	4530_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	SETD1A PDE4A RTEL1 MKI67 FGFR4 DMXL2 ZNF407 RET PPP1R3C VPS13D ARHGEF1	6.59e-06	198	233	11	4762_DN
Drug	Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A	DCTN1 NCDN TMEM161A LMF2 MED22 SPECC1L VPS13D ARHGEF1 NCOA1 PCNX1 AQR	6.59e-06	198	233	11	1287_DN
Drug	sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A	CCNP NCDN LILRA5 SBNO2 ARG2 VPS13D ZNF335 SEC23IP ELF3 SNAPC4 EDA2R	6.92e-06	199	233	11	408_DN
Drug	estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A	SETD1B PPRC1 CCNP AXIN1 DMBT1 HERC1 PRUNE2 DGCR2 ARHGEF12 TG AQR	7.25e-06	200	233	11	665_DN
Drug	AC1L9JWY	PPRC1 PPARG NCOA1	1.04e-05	5	233	3	CID000446639
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRX5 SETD1B PPRC1 MEX3C TRIM8 DIDO1 TACC2 EGR3 SLC35F2 SON	1.17e-05	172	233	10	1072_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	IRX5 SETD1B PPRC1 MEX3C TRIM8 DIDO1 SBNO2 TAF6L EGR3 ELF3	1.29e-05	174	233	10	5945_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	IRX5 SETD1B PPRC1 JUN TRIM8 TACC2 RET SBNO2 EGR3 ZNF335	1.50e-05	177	233	10	5308_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	DENND2A GRAMD1B TTC28 PPARG TAF6L NCOA1 MACF1 PCNX1 AKAP1 SON	1.50e-05	177	233	10	4652_DN
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	DENND2A ABCA2 PDE4A SPTBN2 CEP68 BRCA1 CDC42EP2 SBNO2 VPS13D ARHGEF1	2.20e-05	185	233	10	4327_DN
Drug	Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A	IRX5 PASK MKI67 CDC42EP2 FGFR4 FLT4 RET WRAP53 INF2 MACF1	2.20e-05	185	233	10	5439_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	AXIN1 CEP68 PASK JUN CDC42EP2 PCLO RET WRAP53 EGR3 SNAPC4	2.20e-05	185	233	10	5225_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRX5 POLR1G CEP68 PASK JUN LMF2 CDC42EP2 FLT4 EGR3 SNAPC4	2.31e-05	186	233	10	916_DN
Drug	Azacyclonol [115-46-8]; Up 200; 15uM; PC3; HT_HG-U133A	JUN URB1 SEMA6A DMBT1 FLT4 TG ARHGEF1 ELF3 SNAPC4 DNAAF1	2.53e-05	188	233	10	6298_UP
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A	SETD1A RTEL1 PAGR1 GRAMD1B ATXN7 CDC42EP2 DMBT1 TACC2 PTPRU ELF3	2.53e-05	188	233	10	7104_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	PPRC1 LRRC49 AXIN1 CEP68 JUN CDC42EP2 RET PTPRU EGR3 SNAPC4	2.65e-05	189	233	10	5578_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRX5 POLR1G CEP68 CDC42EP2 RET EGR3 MTRR ELF3 SNAPC4 AKAP1	2.77e-05	190	233	10	1044_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRX5 PPRC1 ZNF318 CEP68 BRCA1 RET INF2 EGR3 AOPEP ELF3	2.90e-05	191	233	10	1063_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	POLR1G MEX3C JUN TMEM161A MED22 TRIM8 CDC42EP2 RET EGR3 AOPEP	3.03e-05	192	233	10	6978_DN
Drug	Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	JUN URB1 CDC42EP2 EHBP1 DMXL2 GDF15 ARHGEF12 GINS4 EGR3 MACF1	3.03e-05	192	233	10	3470_UP
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	IRX5 PPRC1 SLC10A3 ZNF318 CEP68 BRCA1 RET EGR3 AOPEP ELF3	3.03e-05	192	233	10	993_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	IRX5 PPRC1 POLR1G PASK CDC42EP2 ARHGEF12 RET WRAP53 EGR3 AOPEP	3.03e-05	192	233	10	6986_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	NCDN AXIN1 JUN SLC12A9 DGCR2 GINS4 WRAP53 VPS13D PDCL DNAAF1	3.17e-05	193	233	10	3412_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	IRX5 POLR1G NCDN CEP68 JUN LMF2 CDC42EP2 EGR3 SNAPC4 DNAAF1	3.17e-05	193	233	10	5588_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	POLR1G NCDN CEP68 PASK JUN BRCA1 CDC42EP2 RET EGR3 ELF3	3.17e-05	193	233	10	6946_DN
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HG-U133A	DENND2A BCL7B ZNF318 PICALM TMEM161A ARHGEF12 SBNO2 PKMYT1 MTRR SON	3.46e-05	195	233	10	1960_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	POLR1G MEX3C PASK JUN CDC42EP2 RET WRAP53 EGR3 ELF3 AKAP1	3.46e-05	195	233	10	6966_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; HL60; HT_HG-U133A	TMEM94 CAMTA2 DCTN1 NCDN TMEM161A ATXN7 VPS13D EGR3 NCOA1 SNTB1	3.46e-05	195	233	10	1269_DN
Drug	Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; PC3; HT_HG-U133A	ABCA2 RTEL1 AXIN1 CEP68 ZNF407 SBNO2 ARG2 PPP1R3C TAF6L VPS13D	3.46e-05	195	233	10	7140_UP
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	RTEL1 APC2 ATP9B SRCAP DGCR2 ARHGEF12 ZNF407 SORBS1 ZFPM2 INF2	3.46e-05	195	233	10	5115_UP
Drug	6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A	AXIN1 JUN TMEM161A LMF2 BRCA1 CDC42EP2 DGCR2 DMXL2 ZNF335 ARHGAP45	3.46e-05	195	233	10	667_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZNF318 POLR1G HMG20A PASK JUN CDC42EP2 RET VPS13D INF2 EGR3	3.46e-05	195	233	10	6938_DN
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	RTEL1 CEP68 JUN FGFR4 FLT4 TTC28 PTPRU RAB11FIP1 PCNX1 DNAAF1	3.61e-05	196	233	10	2874_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HG-U133A	DENND2A AXIN1 MAP3K9 ARHGEF12 MED1 SBNO2 TG PKMYT1 AKAP1 ARHGAP45	3.61e-05	196	233	10	1958_UP
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HT_HG-U133A	DENND2A RTEL1 NCDN AXIN1 TMEM132A FGFR4 VPS13D INF2 PCNX1 AKAP1	3.61e-05	196	233	10	4645_DN
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A	POLR1G JUN TMEM161A ATXN7 MED22 DMXL2 VPS13D NCOA1 MACF1 BSCL2	3.61e-05	196	233	10	1843_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HT_HG-U133A	DCHS2 PASK HOXB2 ADRA1D GLI2 HSF1 GINS4 SORBS1 AKAP1 SNTB1	3.61e-05	196	233	10	6655_UP
Drug	Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ABCA2 PDE4A RTEL1 SRCAP SLC12A9 FAM76A FGFR4 DMXL2 FLT4 SNAPC4	3.61e-05	196	233	10	2755_DN
Drug	CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A	HOXB2 ADRA1D LMF2 FAM76A AMFR FLT4 PCLO HUWE1 TAF6L AKAP1	3.77e-05	197	233	10	6412_DN
Drug	Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SETD1A RTEL1 ZNF318 CEP68 JUN TMEM161A SLC12A9 IQSEC1 FGFR4 DGCR2	3.77e-05	197	233	10	5300_UP
Drug	Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A	PDE4A SRCAP ZZEF1 URB1 SEMA6A PRUNE2 KIF26B CLIP4 TAF6L AKAP1	3.77e-05	197	233	10	6089_UP
Drug	Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A	ZNF318 PASK LMF2 CDC42EP2 FGFR4 DGCR2 ARHGEF12 PPP1R3C SNAPC4 DNAAF1	3.77e-05	197	233	10	7207_DN
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; PC3; HT_HG-U133A	DENND2A SPTBN2 CEP68 TMEM132A MAP3K9 DGCR2 SORBS1 MTRR ELF3 AKAP1	3.77e-05	197	233	10	4658_DN
Drug	Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A	SETD1B JUN MAP3K9 FGFR4 WRAP53 SBNO2 TAF6L EPHA2 PCNX1 AQR	3.77e-05	197	233	10	3528_DN
Drug	Droperidol [548-73-2]; Up 200; 10.6uM; PC3; HT_HG-U133A	SETD1A MAGEA11 IL16 PDE4A URB1 NRXN2 HSF1 DNAH7 ARHGEF40 INF2	3.77e-05	197	233	10	4629_UP
Drug	Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HG-U133A	DENND2A LRRC49 TMEM161A IQSEC1 ARHGEF12 SBNO2 VPS13D DCHS1 ARHGAP45 SON	3.77e-05	197	233	10	1948_UP
Drug	nocodazole; Down 200; 1uM; MCF7; HG-U133A	ZZEF1 HMG20A CEP68 LMF2 AMFR ARHGEF12 DIDO1 TACC2 RET VPS13D	3.94e-05	198	233	10	621_DN
Drug	Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A	CAMTA2 NCDN ADRA1D CDC42EP2 EHBP1 GINS4 SH2B1 SBNO2 INF2 PDCL	3.94e-05	198	233	10	3440_DN
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	ABCA2 RTEL1 TMEM94 SRCAP DGCR2 ARHGEF12 VPS13D INF2 PCNX1 DNAAF1	3.94e-05	198	233	10	2847_DN
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	ABCA2 RTEL1 TMEM94 ZZEF1 PASK TMEM161A BRCA1 ATXN7 SBNO2 ARG2	3.94e-05	198	233	10	7334_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A	SETD1A ZNF318 AXIN1 PASK HOXB2 MED22 CABP1 MED1 GRM1 ARHGAP45	3.94e-05	198	233	10	7011_UP
Drug	Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; HL60; HT_HG-U133A	PDE4A RTEL1 SLC10A3 AXIN1 CEP68 JUN ADRA1D TAF6L NCOA1 SNTB1	3.94e-05	198	233	10	2528_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; PC3; HT_HG-U133A	AXIN1 HSF1 FLT4 ZNF407 SORBS1 GRM1 SBNO2 PPP1R3C ELF3 DNAAF1	4.11e-05	199	233	10	7281_UP
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	LRRC49 NCDN JUN DGCR2 GINS4 SBNO2 VPS13D EPHA2 MACF1 SNAPC4	4.11e-05	199	233	10	3403_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A	SRCAP AXIN1 PASK ADRA1D IQSEC1 FLT4 SBNO2 CASK PPP1R3C NCOA1	4.11e-05	199	233	10	2449_DN
Drug	butein; Up 200; 10uM; PC3; HG-U133A	PADI4 LRRC49 ZZEF1 LMF2 DGCR2 GDF15 GRM1 SH2B1 VPS13D ELF3	4.11e-05	199	233	10	582_UP
Drug	Iopamidol [60166-93-0]; Down 200; 5.2uM; HL60; HT_HG-U133A	RTEL1 ADRA1D FLT4 MED1 GRM1 WRAP53 SH2B1 ARG2 PPP1R3C TAF6L	4.11e-05	199	233	10	2732_DN
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; ssMCF7; HG-U133A	CCNP DAB2 SLC10A3 SRCAP LMF2 SBNO2 VPS13D BSCL2 SNAPC4 TP53BP1	4.11e-05	199	233	10	498_DN
Drug	Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A	ATP9B SRCAP JUN GDF15 FOS SBNO2 EPHA2 ZNF335 ELF3	4.59e-05	162	233	9	2658_UP
Drug	Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A	ATP9B SRCAP JUN FOS PCLO ARHGEF40 EPHA2 ELF3 SNAPC4	7.64e-05	173	233	9	5612_UP
Drug	WIN55212-2	PPRC1 FOXM1 FOS PPARG PAF1	8.43e-05	44	233	5	CID000005689
Drug	Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A	ZNF318 SRCAP JUN MAP3K9 GDF15 FOS RAB11FIP1 EGR3 EPHA2	8.72e-05	176	233	9	5291_UP
Drug	6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine	APC2 SRCAP DNHD1 GDF15 SLC12A4 EDA2R SON	9.83e-05	104	233	7	ctd:C000595015
Drug	AC1NTCGD	PPRC1 PPARG	1.04e-04	2	233	2	CID005378157
Drug	phenoxybenzoic acid	SEMA6A DGCR2	1.04e-04	2	233	2	CID000075237
Drug	2-[[(2R,3S,4R,5R)-5-[5-[4-(2-amino-6,7-dimethyl-4-oxo-1,5,6,6a,7,9-hexahydroimidazo[5,1-h]pteridin-8-yl)phenyl]-1,2,3,4-tetrahydroxypentoxy]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxypentanedioate	C2 SEMA6A	1.04e-04	2	233	2	CID009543113
Drug	H-Trp-Glu-OH	PPRC1 PPARG	1.04e-04	2	233	2	CID003634442
Drug	rivoglitazone	PPRC1 PPARG	1.04e-04	2	233	2	CID003055168
Drug	Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; HL60; HG-U133A	ZNF318 SRCAP PICALM JUN PPARG ARHGEF40 EGR3 MACF1 PDCL	1.08e-04	181	233	9	1613_UP
Drug	Securinine [5610-40-2]; Up 200; 18.4uM; PC3; HT_HG-U133A	IL16 WAPL HOXB2 FAT2 DGCR2 GDF15 HUWE1 ARG2 ELF3	1.08e-04	181	233	9	4493_UP
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ABCA2 HOXB2 FAM117A SEMA6A FGFR4 FLT4 GDF15 TAF6L EPHA2	1.13e-04	182	233	9	7422_UP
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	SETD1A SRCAP POLR1G DGCR2 RET SBNO2 EGR3 SNAPC4 DNAAF1	1.13e-04	182	233	9	1663_DN
Drug	1,4-bis-(phenoxyacetyl)piperazine	FOXQ1 DAB2 PICALM JUN SNAP91 RET PTPRU GRM1 TG AP3B2	1.14e-04	225	233	10	CID001008511
Drug	Mustard Gas	SETD1A SETD1B PPRC1 KIF1B SRPK2 PAGR1 JUN C2 DMBT1 ARHGAP21 AMTN FOXM1 EHBP1 CABP1 FLNC FRAS1 TTC28 GDF15 FOS HUWE1 RAB11FIP1 CASK ESCO2 EPHA2 RLIM NCOA1 ELF3 DOT1L TP53BP1	1.16e-04	1341	233	29	ctd:D009151
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	IRX5 SLC10A3 CEP68 RET EGR3 AOPEP NCOA1 ELF3 AKAP1	1.22e-04	184	233	9	1064_DN
Drug	17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A	DCHS2 KIF1B SRCAP ZZEF1 ADRA1D TSPYL4 DIDO1 SORBS1 ARG2	1.22e-04	184	233	9	5210_UP
Drug	Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	SETD1A RTEL1 PASK LMF2 GDF15 PCLO PTPRU SBNO2 ELF3	1.27e-04	185	233	9	6243_UP
Disease	testosterone measurement	DCHS2 PDE4A ASCL5 ZNF318 SRCAP POLR1G CSMD3 GRAMD1B CEP68 URB1 C2 ARHGAP21 FOXM1 ANK2 TTC28 R3HDM2 PPARG WRAP53 SH2B1 ZFPM2 ARHGEF40 AOPEP SEC23IP NCOA1 MACF1 EDA2R	5.85e-06	1275	226	26	EFO_0004908
Disease	Familial generalized lipodystrophy	FOS PPARG BSCL2	8.72e-06	6	226	3	C0221032
Disease	Malignant neoplasm of breast	FOXQ1 APC2 ZNF318 JUN TMEM161A LMF2 BRCA1 MKI67 FOXM1 EHBP1 AMFR ANK2 PNLIPRP1 RASGRF2 FOS PPHLN1 TACC2 SORBS1 RFX2 ANKRD30A NCOA1 MACF1 TP53BP1	9.63e-06	1074	226	23	C0006142
Disease	Drugs used in diabetes use measurement	KLF14 EVI2B ZZEF1 HMG20A ATXN7 FGFR4 PPARG DNAH7 CLEC14A MACF1	2.98e-05	255	226	10	EFO_0009924
Disease	Colorectal Carcinoma	SPTBN2 APC2 CSMD3 NCDN MKI67 AMTN TFEC FLNC ANK2 RASGRF2 RET PTPRU PPARG GRM1 ARHGEF1 DCHS1 MTRR	3.27e-05	702	226	17	C0009402
Disease	neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology)	SETD1A SETD1B	5.84e-05	2	226	2	DOID:0070417 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease dominant intermediate E (implicated_via_orthology)	INF2 FHDC1	5.84e-05	2	226	2	DOID:0110205 (implicated_via_orthology)
Disease	congenital generalized lipodystrophy type 2 (implicated_via_orthology)	PPARG BSCL2	5.84e-05	2	226	2	DOID:0111136 (implicated_via_orthology)
Disease	pheochromocytoma (biomarker_via_orthology)	DMBT1 RET	5.84e-05	2	226	2	DOID:0050771 (biomarker_via_orthology)
Disease	cortical surface area measurement	DCHS2 NBEAL1 KIF1B DAB1 SRPK2 NCKAP5 ADGRV1 PICALM AXIN1 ZNF469 TRIM8 SEMA6A ARHGAP21 KIF26B ARHGEF12 DNAH7 TG PKMYT1 PLXDC2 AOPEP MACF1 TNKS ARHGAP27 SNTB1	1.12e-04	1345	226	24	EFO_0010736
Disease	Intellectual Disability	SETD1A TMEM94 APC2 BRCA1 NRXN2 TRIM8 IQSEC1 IQSEC3 SPECC1L ZNF335 RLIM MACF1	1.89e-04	447	226	12	C3714756
Disease	omega-3 polyunsaturated fatty acid measurement, diet measurement	ADRA1D EPHA2 CD96	2.31e-04	16	226	3	EFO_0008111, EFO_0010119
Disease	neuroimaging measurement	DCHS2 NBEAL1 LRRC49 KIF1B DAB1 NCKAP5 STAC2 ZNF469 BRCA1 SNAP91 PROSER3 FOXJ1 KIF26B ARHGEF12 TACC2 TG ARHGEF1 RLIM MACF1 ARHGAP27	2.31e-04	1069	226	20	EFO_0004346
Disease	Agents acting on the renin-angiotensin system use measurement	KLF14 ZNF318 POLR1G MEX3C CEP68 ADRA1D PKMYT1 ZBTB46 PCNX1 PHF13	2.81e-04	335	226	10	EFO_0009931
Disease	breast carcinoma	FOXQ1 PPRC1 KIF1B SPTBN2 ATXN7 GLI2 ANKIB1 PHLDB3 AMFR TTC28 ARHGEF12 TACC2 ZFPM2 PKMYT1 AOPEP ANKRD30A NCOA1 ARHGAP27 DOT1L	3.46e-04	1019	226	19	EFO_0000305
Disease	rectal benign neoplasm (is_marker_for)	FOS WRAP53	3.47e-04	4	226	2	DOID:1984 (is_marker_for)
Disease	Lipoatrophic Diabetes Mellitus	FOS PPARG	3.47e-04	4	226	2	C0011859
Disease	Macrostomia	FRAS1 SPECC1L	3.47e-04	4	226	2	C0024433
Disease	synucleinopathy (biomarker_via_orthology)	KIF1B DCTN1	3.47e-04	4	226	2	DOID:0050890 (biomarker_via_orthology)
Disease	lipodystrophy (is_implicated_in)	PPARG BSCL2	3.47e-04	4	226	2	DOID:811 (is_implicated_in)
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	KLF14 R3HDM2 SPECC1L PPARG ZNF335 MACF1 TNKS TP53BP1	3.52e-04	224	226	8	EFO_0004530, EFO_0008317
Disease	Amyotrophic Lateral Sclerosis, Familial	DCTN1 HSF1 FOS OTOG	5.01e-04	48	226	4	C4551993
Disease	Amyotrophic Lateral Sclerosis, Sporadic	DCTN1 HSF1 FOS OTOG	5.01e-04	48	226	4	C1862941
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	MEX3C JUN LILRA5 FOS R3HDM2 AOPEP	5.33e-04	131	226	6	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	MEX3C JUN LILRA5 FOS R3HDM2 AOPEP	5.33e-04	131	226	6	C4552091
Disease	Juvenile arthritis	MEX3C JUN LILRA5 FOS R3HDM2 AOPEP	5.33e-04	131	226	6	C3495559
Disease	Juvenile psoriatic arthritis	MEX3C JUN LILRA5 FOS R3HDM2 AOPEP	5.33e-04	131	226	6	C3714758
Disease	Global developmental delay	TMEM94 SPTBN2 APC2 TRIM8 IQSEC1 ZNF335	5.77e-04	133	226	6	C0557874
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	DCTN1 HSF1 FOS OTOG	5.86e-04	50	226	4	C1862939
Disease	Tourette syndrome	INSYN1 CSMD3 PICALM PTPRU	5.86e-04	50	226	4	EFO_0004895
Disease	Juvenile-Onset Still Disease	MEX3C JUN LILRA5 FOS R3HDM2 AOPEP	6.24e-04	135	226	6	C0087031
Disease	lateral orbital frontal cortex volume measurement	KIF1B DAB1 OTOG	7.97e-04	24	226	3	EFO_0010312
Disease	cardiovascular disease	WAPL KLF14 ZNF318 AXIN1 MEX3C ADRA1D SORBS1 ZFPM2 EPHA2 PCNX1 PHF13	8.57e-04	457	226	11	EFO_0000319
Disease	probable carboxypeptidase X1 measurement	ZFPM2 CPXM1	8.58e-04	6	226	2	EFO_0801914
Disease	glucagon measurement, glucose tolerance test	HERC1 MACF1	8.58e-04	6	226	2	EFO_0004307, EFO_0008463
Disease	clubfoot (implicated_via_orthology)	FRAS1 RET	8.58e-04	6	226	2	DOID:11836 (implicated_via_orthology)
Disease	spina bifida (is_implicated_in)	GLI2 MTRR	8.58e-04	6	226	2	DOID:0080016 (is_implicated_in)
Disease	leukocyte immunoglobulin-like receptor subfamily A member 6 measurement	LILRA5 LILRB3	8.58e-04	6	226	2	EFO_0801767
Disease	cortical thickness	NBEAL1 LRRC49 SPTBN2 DAB1 NCKAP5 ZNF318 ADGRV1 ZNF469 SNAP91 ARHGAP21 EHBP1 ARHGEF12 TACC2 TG VPS13D ARHGEF40 PLXDC2 MACF1 SNTB1	9.97e-04	1113	226	19	EFO_0004840
Disease	pleckstrin homology domain-containing family A member 1 measurement	DMBT1 ZFPM2	1.20e-03	7	226	2	EFO_0802873
Disease	waist-hip ratio	DAB2 KLF14 SRPK2 ZNF318 ZZEF1 TRIM8 PDZD8 FGFR4 CREB3L3 CORO7 ARHGAP21 PRUNE2 DMXL2 TTC28 ZNF407 PPARG SH2B1 PCNX1 DOT1L SNTB1	1.27e-03	1226	226	20	EFO_0004343
Disease	Mammary Neoplasms, Experimental	PADI4 BRCA1 RASGRF2 CASK LSR NCOA1	1.28e-03	155	226	6	C0024668
Disease	systemic lupus erythematosus	PDE4A DAB2 SRCAP HMG20A LRRC56 C2 CABP1 GDF15 PPARG MED1 SBNO2 ELF3 TNKS ARHGAP27 DOT1L	1.36e-03	799	226	15	MONDO_0007915
Disease	resting heart rate, chronic obstructive pulmonary disease	ADGRV1 HERC1 ZFPM2	1.55e-03	30	226	3	EFO_0000341, EFO_0004351
Disease	syndromic X-linked intellectual disability (implicated_via_orthology)	HUWE1 CASK	1.59e-03	8	226	2	DOID:0060309 (implicated_via_orthology)
Disease	Unilateral agenesis of kidney	FRAS1 RET	1.59e-03	8	226	2	C0266294
Disease	Grand Mal Status Epilepticus	JUN FOS RET GRM1	1.76e-03	67	226	4	C0311335
Disease	Status Epilepticus, Subclinical	JUN FOS RET GRM1	1.76e-03	67	226	4	C0751522
Disease	Simple Partial Status Epilepticus	JUN FOS RET GRM1	1.76e-03	67	226	4	C0751524
Disease	Non-Convulsive Status Epilepticus	JUN FOS RET GRM1	1.76e-03	67	226	4	C0751523
Disease	Petit mal status	JUN FOS RET GRM1	1.76e-03	67	226	4	C0270823
Disease	Complex Partial Status Epilepticus	JUN FOS RET GRM1	1.76e-03	67	226	4	C0393734
Disease	creatinine measurement	CCNP DAB2 ATP9B ADGRV1 GGT7 STAC2 NRXN2 ATXN7 FGFR4 KIF26B R3HDM2 MED1 SBNO2 ARG2 ZBTB46 PLXDC2 AP3B2	1.81e-03	995	226	17	EFO_0004518
Disease	Benign Neoplasm	BRCA1 HSF1 EPHA2 ARHGAP45	1.86e-03	68	226	4	C0086692
Disease	Neoplasms	BRCA1 HSF1 EPHA2 ARHGAP45	1.86e-03	68	226	4	C0027651
Disease	Status Epilepticus	JUN FOS RET GRM1	1.86e-03	68	226	4	C0038220
Disease	lung non-small cell carcinoma (is_marker_for)	AXIN1 BRCA1 MKI67 IQSEC1 FGFR4 WRAP53	1.98e-03	169	226	6	DOID:3908 (is_marker_for)
Disease	Dyskeratosis congenita	RTEL1 WRAP53	2.03e-03	9	226	2	cv:C0265965
Disease	Spinocerebellar Ataxia Type 2	SPTBN2 ATXN7 GRM1	2.23e-03	34	226	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	SPTBN2 ATXN7 GRM1	2.23e-03	34	226	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	SPTBN2 ATXN7 GRM1	2.23e-03	34	226	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	SPTBN2 ATXN7 GRM1	2.23e-03	34	226	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	SPTBN2 ATXN7 GRM1	2.23e-03	34	226	3	C0752124
Disease	Ataxia, Spinocerebellar	SPTBN2 ATXN7 GRM1	2.23e-03	34	226	3	C0087012
Disease	alkaline phosphatase measurement	ELP5 BCL7B ZNF318 ANKRD54 AXIN1 SLC12A9 MED22 TRIM8 MAMSTR DMBT1 ARHGAP21 GDF15 PPARG SBNO2 MACF1 TNKS TP53BP1	2.23e-03	1015	226	17	EFO_0004533
Disease	sexual dimorphism measurement	KLF14 ZZEF1 GGT7 CAMKV GLI2 MED22 FGFR4 HERC1 LILRA5 FOXM1 ZBTB46 ARHGEF40 AOPEP ZNF335 MACF1 TNKS DOT1L TP53BP1	2.27e-03	1106	226	18	EFO_0021796
Disease	Spinocerebellar Ataxia Type 4	SPTBN2 ATXN7 GRM1	2.42e-03	35	226	3	C0752122
Disease	sleep duration, high density lipoprotein cholesterol measurement	TMEM94 KLF14 LILRA5 SLC12A4 MACF1	2.44e-03	121	226	5	EFO_0004612, EFO_0005271
Disease	C-reactive protein measurement	DCHS2 BCL7B CCNP ZZEF1 ZNF469 CAMKV CREB3L3 ARHGAP21 CABP1 DMXL2 R3HDM2 ZFPM2 LRRC55 ZBTB46 AOPEP MACF1 TNKS SNAPC4 TP53BP1	2.48e-03	1206	226	19	EFO_0004458
Disease	axial length measurement	AXIN1 HMG20A ZNF469 SNTB1	2.93e-03	77	226	4	EFO_0005318
Disease	glomerulosclerosis (implicated_via_orthology)	PPARG INF2	3.07e-03	11	226	2	DOID:0050851 (implicated_via_orthology)
Disease	follistatin measurement	R3HDM2 TP53BP1	3.07e-03	11	226	2	EFO_0010614
Disease	Malignant Neoplasms	BRCA1 HSF1 RET EPHA2 ARHGAP45	3.11e-03	128	226	5	C0006826
Disease	lung cancer (is_marker_for)	AXIN1 MKI67 ESCO2	3.31e-03	39	226	3	DOID:1324 (is_marker_for)
Disease	alcohol consumption measurement	SETD1A WAPL BCL7B NCKAP5 ADGRV1 CSMD3 HMG20A SNAP91 MAMSTR EHBP1 RASGRF2 GDF15 PCLO MED1 WRAP53 SH2B1 ESCO2 CLIP4 ARHGAP27	3.41e-03	1242	226	19	EFO_0007878
Disease	nervous system disease (implicated_via_orthology)	KIF1B ATP1A4	3.66e-03	12	226	2	DOID:863 (implicated_via_orthology)
Disease	motor neuron disease (implicated_via_orthology)	DCTN1 WRAP53	3.66e-03	12	226	2	DOID:231 (implicated_via_orthology)
Disease	Mouth Diseases	BRCA1 GDF15	3.66e-03	12	226	2	C0026636
Disease	protein FAM3D measurement	MED22 MAMSTR	3.66e-03	12	226	2	EFO_0021869
Disease	very low density lipoprotein particle size measurement	KLF14 FOXM1 PPARG TNKS TP53BP1	3.67e-03	133	226	5	EFO_0008594
Disease	age-related hearing impairment	DENND2A ZNF318 CSMD3 LMF2 SNAP91 TTC28 ZFPM2 CD96	3.67e-03	324	226	8	EFO_0005782
Disease	snoring measurement	ADGRV1 SNAP91 AOPEP MACF1	4.01e-03	84	226	4	EFO_0008341
Disease	childhood gender nonconformity	WAPL SPTBN2 JUN	4.37e-03	43	226	3	EFO_0020103
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	KLF14 FOXM1 PPARG ZNF335 MACF1 SNTB1 TP53BP1	4.40e-03	264	226	7	EFO_0008317, EFO_0020944
Disease	cataract	PKD1L1 PROSER3 TTC28 EGR3 TNKS	4.70e-03	141	226	5	MONDO_0005129
Disease	S-6-hydroxywarfarin to S-warfarin ratio measurement	CSMD3 KIF26B TACC2 ZFPM2	4.73e-03	88	226	4	EFO_0803332
Disease	Animal Mammary Neoplasms	PADI4 BRCA1 RASGRF2 CASK LSR	4.84e-03	142	226	5	C0024667
Disease	Mammary Carcinoma, Animal	PADI4 BRCA1 RASGRF2 CASK LSR	4.84e-03	142	226	5	C1257925
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	FLNC DNAAF1	5.00e-03	14	226	2	DOID:898 (implicated_via_orthology)
Disease	urinary bladder cancer (biomarker_via_orthology)	MKI67 PPARG	5.00e-03	14	226	2	DOID:11054 (biomarker_via_orthology)
Disease	nausea and vomiting of pregnancy severity measurement	GDF15 SPECC1L	5.00e-03	14	226	2	EFO_0009265
Disease	insulin metabolic clearance rate measurement, glucose homeostasis measurement	ZZEF1 HMG20A	5.00e-03	14	226	2	EFO_0006830, EFO_0006896
Disease	coronary artery disease	NBEAL1 DAB1 KLF14 DMXL1 GGT7 C2 CORO7 ARHGAP21 EHBP1 ARHGEF12 PPHLN1 R3HDM2 SPECC1L PTPRU ZFPM2 ZBTB46 ZNF335 TNKS	5.04e-03	1194	226	18	EFO_0001645
Disease	Primary Ciliary Dyskinesia	LRRC56 FOXJ1 DNAAF1	5.61e-03	47	226	3	C4551720
Disease	response to olanzapine	ADGRV1 ZFPM2	5.74e-03	15	226	2	GO_0097333
Disease	head and neck squamous cell carcinoma (is_implicated_in)	FGFR4 WRAP53	5.74e-03	15	226	2	DOID:5520 (is_implicated_in)
Disease	obsolete aging	KLF14 AXIN1 SNAP91 MED22 IQSEC1 CREB3L3 PKMYT1	5.91e-03	279	226	7	GO_0007568
Disease	apolipoprotein A 1 measurement	KLF14 MED22 FGFR4 CREB3L3 HERC1 LILRA5 AMFR R3HDM2 PTPRU PPARG ZFPM2 MACF1 SNTB1 TP53BP1	6.04e-03	848	226	14	EFO_0004614
Disease	serum albumin measurement	ADGRV1 ZZEF1 ANKRD54 FAM117A FLT4 R3HDM2 PPARG ZBTB46 EPHA2 MACF1 TP53BP1	6.23e-03	592	226	11	EFO_0004535
Disease	lung adenocarcinoma (is_implicated_in)	IQSEC1 FGFR4 ESCO2	6.30e-03	49	226	3	DOID:3910 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
TVLGPDTAEPATAEA	AKAP1	396	Q92667
TEPFSGTTSVLDTPD	CABS1	356	Q96KC9
SLESLAPPESTDEGA	ARHGEF1	356	Q92888
LSADTAGDRPPDSLT	ATG4A	191	Q8WYN0
SLAPETLDSSGDVSP	ARHGEF40	1461	Q8TER5
DIDAFDPTLAPATGT	ARG2	251	P78540
TSTGTPDEAAPLAER	ANKRD30B	276	Q9BXX2
APEPLTDAEGLFSFA	ANKRD54	26	Q6NXT1
DGEARAPSSLVPESS	ASCL5	246	Q7RTU5
DSPESPILGTFTGAE	CSMD3	781	Q7Z407
VFEDGADTTSPETPD	DCTN1	96	Q14203
QSPLEVSDSDGPASF	CEP68	516	Q76N32
PNPDSDDFLSSILGS	CREB3L3	56	Q68CJ9
ESGAAADTPPLETLS	AAMP	6	Q13685
ADTPPLETLSFHGDE	AAMP	11	Q13685
EEATSPGPDLAFLTS	FAM117A	351	Q9C073
SSSDSVFSHDPLPLG	FGFR4	776	P22455
FSPESLFVSGTEPED	ADGRV1	1866	Q8WXG9
TSAGTPDEAAPLAER	ANKRD30A	276	Q9BXX3
SSSSGFAEPLEIRPS	CAMTA2	296	O94983
DLFLEAPASGSSDPL	CPXM1	281	Q96SM3
DALDAPSSSESEGIP	SPECC1L	361	Q69YQ0
TSPDEISLSPGDLDT	ANKIB1	316	Q9P2G1
LASVPPAATFGADDL	ELF3	26	P78545
ETGATSTPEAIPALS	AQR	1441	O60306
SNDLATERPFSPSEA	AOPEP	356	Q8N6M6
RLPTPSGTDDDFAVT	AMTN	171	Q6UX39
AATATTAPPALDIFG	SNAP91	551	O60641
FPIAGLEFSELPVTS	DMXL2	2526	Q8TDJ6
PASFSDPETRSAVEL	FAM187A	366	A6NFU0
VQAFPPDSSLLDSAS	DNHD1	131	Q96M86
LTPGAEPATLDESSS	DOT1L	956	Q8TEK3
LAASLDAEPSSAAVP	CCNP	31	Q9H8S5
DSASESTLSLPPGEE	CLIP4	396	Q8N3C7
TSDFRTDDSQPPTLG	BCL7B	126	Q9BQE9
GDSVPAAASEADPFL	CABP1	191	Q9NZU7
RSVDLVSSVDGSPPF	DMXL1	1201	Q9Y485
GSSEAPVSFDGLPLE	GRAMD1B	291	Q3KR37
STESFAPRDSVGLAP	ARHGEF12	1331	Q9NZN5
EFPEIESLAPGESAT	AP3B2	921	Q13367
TPLFPEDSSVGELSF	NBEAL1	1341	Q6ZS30
SSTPFADGPLETQDI	R3HDM2	86	Q9Y2K5
TGRDLFSLDSEDPSP	PAGR1	221	Q9BTK6
GSLEPSAIPNDSDLT	PCDHGA2	676	Q9Y5H1
GPRVETPDSSSEEAF	INSYN1	151	Q2T9L4
GRETFSLTFPEELSP	IREB2	906	P48200
SLSDSDFKEPPSEGR	IRX5	246	P78411
AFSPSLSQGPDSAEE	PCDHA2	771	Q9Y5H9
PASLDPTAGSLSVAE	KIAA1549	531	Q9HCM3
ATGADPLPLETSAES	ANK2	3151	Q01484
FPDTDFPGLITLTIS	PADI4	256	Q9UM07
TESLEASALPPAVGD	PHLDB3	416	Q6NSJ2
AGPPKDISSDAFTAL	DAB2	626	P98082
LLTFLESSTGSPEEP	FHDC1	551	Q9C0D6
PPGSTLLTLEATDAD	DCHS1	2496	Q96JQ0
EELPDFSEDPTSSGL	CASK	326	O14936
LRETPSSLAVGSDPD	PASK	766	Q96RG2
PEVEGAPLFSLTEES	LRRC55	231	Q6ZSA7
SEPSDLLEIPVSGAA	LILRA5	226	A6NI73
RFGPETASDLEASFP	FRAS1	1891	Q86XX4
VDSSTLLAVPPGDSS	ARHGAP45	226	Q92619
STSPDLIDPESFSQD	MAGEA11	206	P43364
EQEGPSTFPDLETSF	MAGEA12	91	P43365
PILSTFLTARGDPDD	NCDN	131	Q9UBB6
QTGPLRSSLEESPFE	MDP1	161	Q86V88
DFLFPASSRPSGSET	FOS	271	P01100
TSSTLPPLFADEDGS	HMG20A	6	Q9NP66
DDALNASFLPSESGP	JUN	11	P05412
DISPIGRDPSESSFS	KIF1B	1611	O60333
DSADGLSAPLLASPE	MED22	161	Q15528
DFPEDVAPALGTSFS	C2	211	P06681
SFEGTFTREDSDPPI	ATP9B	311	O43861
PAPSSDFADAITELE	IQSEC1	226	Q6DN90
IDGSEEPSSFPFEEL	KIF26B	936	Q2KJY2
EEISGALPVASPASS	MTRR	161	Q9UBK8
PLEESFSTEFGPENL	ZFPM2	41	Q8WW38
DAEESLGSPSDPSFS	HERC1	3476	Q15751
LPDLGTESLFSSPEE	DCAF8L2	11	P0C7V8
DADASEGFSSPPSSL	CORO7	421	P57737
DSPDLLLEAGDPATS	FBXW5	261	Q969U6
FAEDPTISLLTGSEP	HSF1	506	Q00613
LPPISADTRDQFGSS	PCLO	4381	Q9Y6V0
DLSPDLAATYGPTEE	PCNX1	951	Q96RV3
EDLPPGTVLTFLDAS	FAT2	936	Q9NYQ8
LGDPDTDPDSFLKSA	GGT7	51	Q9UJ14
TGLDPVEASFESTPE	PNLIPRP1	191	P54315
SPAEDTPATLSADLA	SLC10A3	171	P09131
DSQPFSSISDDLFGP	PDZD8	1136	Q8NEN9
TGSAPVAPDEFSSRE	PDE4A	786	P27815
VGTAVSSSDDADLPP	EVI2B	326	P34910
ASGIPASLPVEFTID	FLNC	1551	Q14315
TSEAGPSSVPDLALA	IL16	66	Q14005
ASGEVFDSSLPPTDD	NRXN2	1496	Q9P2S2
NLPSPEEDGFTISLS	KIF24	976	Q5T7B8
ALDAALPSPEEGTSI	MACF1	846	O94854
TLSAFPEETGPLDSG	LRRC49	381	Q8IUZ0
SSPRPDGVEDSTEFV	GBP6	156	Q6ZN66
ALDDTPPGADTSALA	GLI2	696	P10070
SLAEASRASFPGPSE	GDF15	31	Q99988
ASPPSSLSGEFLDTK	LILRB3	556	O75022
TDSGEEPLLPTSESF	MKI67	791	P46013
TSSEEEDPLAGISLP	HUWE1	2951	Q7Z6Z7
SLPPTFAGTLTELED	IQSEC3	386	Q9UPP2
LPATEPASRLSSEEG	ATXN7	481	O15265
SLSSPDAEAVEPDFS	INF2	586	Q27J81
SVDPDSPAEASGLRA	SLC9A3R1	181	O14745
ESTPSLDAGLAELAP	NUTM1	631	Q86Y26
PSGIAAESLTFTPLE	PTPRU	486	Q92729
ATDAGSPPLSTEETL	DCHS2	511	Q6V1P9
LQGSLDSPVPFSEEE	HOXB2	326	P14652
SGEVFDSSLPPTDDE	NRXN2	451	P58401
TLVLDSPFLESGVSP	FANCD2OS	56	Q96PS1
VIFDSDPAPKDTSGA	PAF1	221	Q8N7H5
SGISLFSDDPESDPS	BRCA1	1566	P38398
AATGEPASPAALSLF	APC2	791	O95996
LVPFASDSDSLDSPN	GRID2IP	356	A4D2P6
TTAAAPTPEETGDFL	BNIP5	71	P0C671
SGLTPESGAEEPFLS	CDC42EP2	161	O14613
PVSTGDLDRALPADT	DACT2	216	Q5SW24
ATPATDGRATPATEE	CAMKV	426	Q8NCB2
PTTDDIFEEGFESPS	DAB1	536	O75553
STPSSPDDIFFNLGD	DENND2A	456	Q9ULE3
PEEIPSALNLFSGSS	EGR3	26	Q06889
FPETIAGSDAPSLAT	EPHA2	211	P29317
DTLSLTDSSVDGIPP	AXIN1	331	O15169
DADLDSAVPDGSTIP	DNAH7	136	Q8WXX0
AVPEVASEPGLESAS	DIDO1	906	Q9BTC0
SESRSPPEGDTTLFL	DIDO1	1036	Q9BTC0
PEPLFEAGDATLASD	FOXJ1	396	Q92949
TAEEGAPSAAALATP	ABCA2	381	Q9BZC7
FGDPDSEEPITETAS	EHBP1	281	Q8NDI1
PLPTAGASLADLEDS	DGCR2	496	P98153
FLSTDEIAFSDPTPD	ESCO2	566	Q56NI9
DVLSPSPDSEGLSSV	MAMSTR	336	Q6ZN01
GDRDSDFLAASSPVP	DNAAF1	676	Q8NEP3
DEPELLFSEGPSTSR	FOXM1	556	Q08050
IDPPLTSEVESSASG	KLF14	296	Q8TD94
PDFSLDLQEGPSVES	ELP5	221	Q8TE02
QLSTFGEELVSPPAD	GRM1	1081	Q13255
ASAPVLETLGSSEPA	BSCL2	371	Q96G97
PDFDLSSSSSGISPD	CEP295	2086	Q9C0D2
EGSPFPSESTLESTV	DMBT1	46	Q9UGM3
DSEGLPVSLPAAVDT	PKD1L1	721	Q8TDX9
PVDPGLVDLASTSSE	PPRC1	606	Q5VV67
EAGSTAPLFTDQPEE	PPHLN1	256	Q8NEY8
FASSSSTVEERPGLP	MAP3K9	1036	P80192
DSPSSPLGAEDLLSD	CNTROB	6	Q8N137
TDPADLIADAAGSPS	MED1	836	Q15648
SDAPSPLSAAGDDSL	FOXQ1	26	Q9C009
ALDDLTPPSTAESGS	LSR	496	Q86X29
SGDSAQDTSLIPAPF	nan	841	A6NNC1
APASSSVPAEAELAG	PDCL	36	Q13371
DEATTEPSGRSAPAL	OTOG	2016	Q6ZRI0
RPSLSAAVFEDSLPG	MOS	296	P00540
EDAVSEAKSPGPFFS	RTEL1	771	Q9NZ71
AGPEDPSLSVTLADI	TAF6L	426	Q9Y6J9
VPFALSLSSDGAVSP	RAB11FIP1	726	Q6WKZ4
FEAEVARASGSLSPP	SH2B1	76	Q9NRF2
DSPAGVRTAFTDLPE	SNTB1	86	Q13884
DPVSLSTPLETEFGS	WRAP53	71	Q9BUR4
STPLETEFGSPSELS	WRAP53	76	Q9BUR4
SLTDFVGDESPSPER	PRUNE2	586	Q8WUY3
ASNLGEDSVPSPLDT	PRUNE2	951	Q8WUY3
FVSAAGDELTPETPT	PRUNE2	1941	Q8WUY3
TDSDTFSFAIDLPPV	PPP1R3C	211	Q9UQK1
LAPLEPDSGTSSAAD	PSD	461	A5PKW4
EGEPSSLSPEELAFA	GINS4	116	Q9BRT9
AGLTEPDSSPLELSE	TMEM132A	331	Q24JP5
PPFGETRFSLLSDSA	TMEM161A	296	Q9NX61
FPVAPSSALASSEDL	TMEM255B	276	Q8WV15
VEEFFPSVSLGDPTL	LMF2	581	Q9BU23
PDPADSSDFLALAGL	LRRC56	371	Q8IYG6
IDSSLPSGFASPTNE	NCKAP5	376	O14513
TSLPASDEDPEGAVL	RFX2	411	P48378
LESAPADRAGVESSP	RASGRF2	826	O14827
EGSPSDITTLSVEPD	NCOA1	696	Q15788
GDSPIDPESDSFTDT	PPARG	6	P37231
DLAVDSPAFDSLPTS	MEX3C	491	Q5U5Q3
ESPFEAAEGAASPAT	ARHGAP27	276	Q6ZUM4
SVGQDSPEPRSFTDL	PLXDC2	81	Q6UX71
SPEPRSFTDLLLDDG	PLXDC2	86	Q6UX71
ESPRFSLEALTGPDT	POLR1G	26	O15446
PEAISSSADPGLEES	SLCO5A1	826	Q9H2Y9
SSADPGLEESPAALE	SLCO5A1	831	Q9H2Y9
LSSFPVELESPGLAE	SELENOO	461	Q9BVL4
GNLEDPSEFETPALS	SGO2	756	Q562F6
PGLDSDFNSSPESLV	SBNO2	661	Q9Y2G9
PEEPTATAAFGARDS	SETD1B	411	Q9UPS6
TSSDGLSPFSETFIP	PROSER3	231	Q2NL68
SPASLLLPGEDSTDV	SEC23IP	46	Q9Y6Y8
TNGDSFSPDLALDSP	FAM76A	196	Q8TAV0
APEPLAEGAAAEFSS	SLC35F2	11	Q8IXU6
VSESNGLELPPSAAS	SRCAP	2646	Q6ZRS2
AEPLPSSSVSGEEAR	SETD1A	756	O15047
LPTLLTSDGEESPDS	URB1	1486	O60287
SSPFLSPLEASRGID	SLC12A4	46	Q9UP95
FLPSEGASSDPVTLR	AMFR	611	Q9UKV5
LLSVSFEGPRPDSSA	ADRA1D	6	P25100
LTGESEPQSRSPDFT	ATP1A4	226	Q13733
AALDFSPPGTEVSAL	CLEC14A	201	Q86T13
PFSATVDAVDDAIPS	PICALM	421	Q13492
LADTELEDFTPSGPL	ULBP3	106	Q9BZM4
DAGFSDIASSVPLPV	PHF13	71	Q86YI8
FEEGSSPTLLDADFP	ZBTB21	511	Q9ULJ3
TDGLSEPDVFAIAPF	nan	116	Q6ZSR9
FLLGSEISSTDPPLS	CD96	376	P40200
TAVASEEGPATLPEA	SPTBN2	1086	O15020
PPEFTAGLSSELRSV	PKMYT1	321	Q99640
SFQPTDSDIPSFLED	TMEM94	931	Q12767
AGAGFPEDSEPISIS	SEMA6A	16	Q9H2E6
DSASPVFTAPAESEG	STAC2	256	Q6ZMT1
APVTFDESGSLPFLS	RLIM	516	Q9NVW2
AESPEAAGVSSTAPL	TNKS	151	O95271
FLTDPAFSEPADSTR	SLC12A9	641	Q9BXP2
AFSEPADSTREGSSP	SLC12A9	646	Q9BXP2
ASAASPLTFPTLDDF	SORBS1	196	Q9BX66
PEFSTSLFSGSLEPV	SRPK2	451	P78362
FATPLAASLEEVAPG	FLT4	616	P35916
EDAPPSTKGLEAASA	TSPYL4	91	Q9UJ04
DPFGFDSDDESLPVS	WAPL	71	Q7Z5K2
DSPTDLSSPTDVGLD	SEZ6	256	Q53EL9
TSLFPEIATALPDGS	USF3	2191	Q68DE3
PSEAIEITAPEGSFA	TACC2	2626	O95359
TSGTEPADFALPSSR	TP53BP1	1341	Q12888
DDSAPTFPAGVDTAS	RET	266	P07949
SPLLEAEAGRPSDVS	nan	146	Q8IYB0
SAPDSTEFTEALRSP	ZNF469	1206	Q96JG9
PFSPTGADSIASDAI	TTC28	1976	Q96AY4
KPTSSPDTGFAEDDI	USP37	731	Q86T82
SGLPAADVSPATAEE	ZZEF1	1501	O43149
ALPLAPVFSEAEGTA	SNAPC4	986	Q5SXM2
DTISPFGTDPLLSAT	TFEC	311	O14948
SSLPEDIPVFTAAAA	TARBP2	116	Q15633
SEAGVAPPEASSALD	ZNF407	1976	Q9C0G0
LAATEPAVSVPSGDL	nan	31	Q8N1Y9
TAFPEASFLETSSGP	TRIM8	381	Q9BZR9
DSESEFPVFPTALTS	ARHGAP21	1636	Q5T5U3
PILEDDCSSTSGFPT	EDA2R	216	Q9HAV5
ADGSISFPSPDALAS	ZNF335	941	Q9H4Z2
AGEPSTLAAPTSAAE	ZNF579	176	Q8NAF0
PTEAGLTTELFSPVD	TG	1846	P01266
AAIPSDETAPGVSES	ZNF318	1511	Q5VUA4
ETLSSTGPFALEPDA	SON	1591	P18583
VEDDSRASSPVPSFL	ZBTB46	286	Q86UZ6
SKAPEDSSGDLIFPS	VPS13D	2176	Q5THJ4
SSPGDTETTLLPDDT	MUC12	3086	Q9UKN1
EAQPVTDFGPDESLS	NALCN	11	Q8IZF0